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Abstract
Sepsis is an excessive inflammatory response to infection that leads to multiple organ failure.
The high mortality rates in the intensive care unit have remained stagnant, which can be
attributed to the disconnect between the bench and the bedside. There is a global need for an
animal model of sepsis that is more relevant to the clinical scenario. We developed an in vivo
rat model of sepsis, with a high level of instrumentation, to monitor macrovascular and
microvascular changes over the course of a feces-induced peritonitis (FIP).
In addition, early fluid resuscitation of septic patients is associated with better clinical
outcomes; however, the type of fluid used for resuscitation is highly disputed. The first
application of our in vivo model was to use clinical resuscitation targets to test the effect of
fluid type (crystalloid or colloid) on both the microvasculature and the systemic circulation.
Keywords: sepsis, feces-induced peritonitis, colloid, crystalloid, microcirculation
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Chapter 1
Introduction and Background
1.1

Thesis Outline

This thesis was motivated by the needs of ICU physicians, and sepsis researchers alike, to
provide a well-controlled animal model that is representative of human sepsis. The
disparity between the bench and the bedside has been brought to light recently, due to the
failure of several clinical trials aimed at improving the survivability of sepsis. The aim of
this model was to provide a platform to test common ICU interventions, and attempt to
explicate the impact of these interventions on the microvascular environment surrounding
the vital organs. The difficulties in developing a working animal model of sepsis that has
clinical applications furthered our understanding of the complexity of the sepsis state, and
made clear the challenges of translational research. These difficulties are minor, however,
when compared to the difficulty in understanding the human sepsis condition given the
multitude of potentially confounding variables, routes of infection, and patient
backgrounds.
This thesis is divided into four chapters. The first chapter provides an introduction to the
current state of sepsis in the ICU, and the issues surrounding translating bench-side
research to clinical practice. It also summarizes current therapies aimed at restoring
macrovascular and microvascular circulation. This chapter further outlines the issues with
current animal models of sepsis, and highlights some important aspects of an “ideal”
translational model.
The second chapter outlines the development of an animal model of sepsis that is more
clinically relevant. In collaboration with ICU physicians, we demonstrate our two-sided
(macrovascular and microvascular) instrumentation techniques, which provide data
similar to what would be available in the critical care environment. To illustrate the
similarity in acquired measurements, this chapter also shows sample data collected from
a septic animal.
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The third chapter of this thesis demonstrates an application of our model addressing a
common debate among clinicians as to which fluid should be used for resuscitation. This
experiment was guided by clinical resuscitation targets, and aimed to elucidate the
mechanistic effect of different fluids on microvascular restoration in sepsis. Two of the
most common fluids used clinically, saline and albumin, were tested as the first
application of the model. This chapter provides preliminary data for each fluid type used
for resuscitation, and illustrates the associated microvascular effect of achieving
hemodynamic optimization targets.
The final chapter provides a critical discussion of experimental findings, and explores
potential additions to improve the fidelity of the model. Lastly, this chapter explores
possible future applications of our model.

1.2

Sepsis

Sepsis is a systemic inflammatory response to infection that causes a wide range of
clinical conditions in an unpredictable manner. The pathogenesis of sepsis can involve
multiple organ systems, and is characterized by an initial inflammatory phase comprised
of increased cardiac output, low systemic vascular resistance, and heterogeneity of
microvascular blood flow, depleted blood volume due to increased vascular permeability,
and decreased blood pressure[1, 2]. This is followed by an immunosuppression phase,
which involves decreased cardiac output, low systemic vascular resistance, and
respiratory distress in tissue cells, tissue edema, and indications of hypoxia within the
vital organs. The progression of sepsis is rapid, the symptoms between patients are
inconsistent, the site of infection is variable, and the timing of intervention is critical to
survivability[3-6]. For this reason, despite major improvements in the quality of patient
care, sepsis mortality rates have remained stagnant.
A landmark epidemiology study analyzing the healthcare burden of severe sepsis in the
United States, demonstrated that the cost of sepsis to the healthcare system in 1995 was
$16.7 billion annually, with over 800,000 diagnosed cases. [5]. With an associated
mortality rate of 30%, sepsis was the leading cause of death in the intensive care unit.
Despite an increased knowledge of the pathophysiology of sepsis, the mortality rate of
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patients with severe sepsis remains stagnant. Over 70 multi-center clinical trials have
been implemented, aimed at improving the survivability of sepsis, and most of them
failed to show a positive survival benefit[7].This can be attributed to the difficulty in
defining sepsis, and the degree of disconnect between the bench and the bedside[7, 8]. It
has also recently been recognized that consideration of the microcirculation in sepsis may
lead to improved survivability[9].

1.3

The Microcirculation in Sepsis

The microcirculation (vessels <100µm in diameter) is responsible for transporting oxygen
and nutrients to tissue cells and, if needed, delivers therapeutics. This network of
arterioles, capillaries, and post-capillary venules form the microcirculatory unit that is
severely affected in sepsis. Within this network, endothelial cells line the inside of the
vessels, and smooth muscle cells regulate arteriolar tone, while red blood cells,
leukocytes, platelets and plasma form the components of the blood[10]. The transport of
oxygen occurs primarily at the capillary level, and involves passive diffusion of oxygen
from the arterioles and the capillaries to the surrounding environment[11]. This system is
highly regulated and, in healthy individuals, has the ability to distribute blood flow to
meet the unique oxygen requirements of each tissue. In sepsis, the microvascular system
is compromised, and oxygen transport to the vital organs is severely affected. The
restoration of tissue perfusion is intimately linked to survival in sepsis[12].
The microcirculatory alterations common in sepsis include: an increase in the amount of
stopped flow capillaries, maldistribution of oxygen delivery to tissue, increases in
arteriolar diameter, and increased spatial distance between perfused capillaries for
oxygen diffusion[1, 13, 14]. Within this network, endothelial cell swelling, leukocyte
trafficking and stiffness, disruption of vascular tone regulation, stiff red blood cells, and
fibrin/platelet clotting can lead to stopped flow in capillaries, and further compromised
tissue function[15, 16].
The early septic response in humans is associated with a hypodynamic phase in which
there is an imbalance between the oxygen demands of tissue, and the necessary supply to
maintain proper organ function. This leads to global tissue hypoxia, and the recognition
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of this phase incites early goal-directed therapy implementations aimed at optimizing
systemic hemodynamic parameters in an attempt to restore tissue oxygenation[3]. Despite
this optimization, microcirculatory perfusion can remain impaired [17, 18]. It follows that
compromised microvasculature common to sepsis, and the associated hypoxic conditions
in tissue, initiates a cascade of pathogenic mechanisms that could eventually result in
organ failure[10]. The relationship between impaired oxygen extraction and mortality in
sepsis has been known for decades; however, the emergence of bedside technology
allowing for the observation of patient microcirculation has illustrated the importance of
considering the microcirculatory environment given the pivotal role it plays in sepsisinduced organ dysfunction [10, 12, 15, 16, 19]. For this reason, goal-directed therapies
aimed at re-establishing macrovascular homeostasis exclusively may be insufficient in
restoring microcirculatory flow in the tissues of septic patients and thus do not prevent
organ failure [20, 21].
It is well known that heterogeneous distribution of blood flow in sepsis causes some
capillaries to be under perfused, while some capillaries remain normal or highly
perfused[13]. This maldistribution of blood flow greatly increases the diffusion distance
of oxygen in the capillary bed, which can quickly cause hypoxic conditions. The low
levels of mixed-venous oxygen saturation, and high lactate levels at the onset of sepsis,
are indicative of this response. The production of lactate is indicative of anaerobic
metabolism, which is related to tissue hypoxia, due to decreased oxygen extraction[22].
Lactate could also increase due to mitochondrial failure, or due to abnormalities in
pyruvate dehydrogenase activity[23, 24]. The decrease in oxygen extraction ratio despite
increased cardiac output in the hyperdynamic phase of sepsis could be due to impaired
mitochondrial respiration, reducing the utilization of available oxygen[25]. On the other
hand, it could also be due to heterogeneity of flow caused by microvascular injury, which
causes inadequate oxygen supply to some regions of tissue[1, 26].
Endothelial cells play an important role in sensing flow, and have the ability to transmit
upstream information about the downstream microcirculatory conditions[27]. These cells
also have regulatory properties that control microvascular tone, permeability and
capillary recruitment, as well as controlling coagulation and immune function[28]. In
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sepsis, the endothelial cells do not function properly, which causes loss of cell-to-cell
communication and smooth muscle control. The dysfunction of endothelial cells in sepsis
thus has a marked effect on microcirculatory perfusion. Endothelial-cell-mediated
microvascular

dysfunction

causes

arteriolar

vasodilation,

leukocyte

adhesion,

microvascular permeability, compromised cell-to-cell communication, altered functional
capillary density, maldistribution of capillary blood flow, and abnormal oxygen transport
and tissue oxygenation[1, 10, 20, 27]. Furthermore, erythrocytes are also affected in
sepsis and become less deformable, which affects their ability to release nitric oxide in
the presence of hypoxia to cause a vasodilatory response[29]. Taken together, the
microvascular environment is dysfunctional, leading to a severe decrease in peripheral
vascular resistance, tissue edema, myocardial and multiple organ microvascular
dysfunctions.
It is not clear whether or not therapeutic interventions (e.g. fluid resuscitation,
vasodilators, vasopressors) aimed at improving global oxygen delivery to tissue will be
effective if there is not an increase in microvascular recruitment and flow. A major focus
of this thesis was to utilize imaging techniques to quantify the degree of microvascular
failure in the capillary bed of an animal throughout the onset of an applied septic insult.
Dual-wavelength intra-vital video microscopy provided the unique ability to measure
velocity, supply rate, hematocrit, and oxygen saturation for single capillaries, which
illustrates the mechanistic effect of microvascular dysfunction in sepsis.

1.3.1 Microcirculatory Monitoring in the ICU
It is well established that a poorly functioning microvascular system leads to multiple
organ failure and poor prognosis in sepsis[30]. Despite therapies aimed at re-establishing
macrovascular homeostasis and improving global oxygen delivery (fluid resuscitation,
vasopressors, inotropic agents, vasodilators, blood transfusions), the inability to reperfuse hypoxic capillary beds renders these interventional techniques ineffective[10,
31]. The ability to assess the degree of microvascular dysfunction in the ICU is thus a
valuable tool to provide insight into the severity of sepsis, and the environment
surrounding the vital organs[32].
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Laser-Doppler, and forearm ischemia reperfusion techniques can measure regional
microvascular alterations; however, these methods do not take heterogeneity of flow into
account, which leads to underestimation of the severity of microvascular dysfunction in
sepsis[33]. In order to address the need for observation of the microvasculature at the
bedside, side-stream dark field (SDF) imaging was developed and can be implemented in
critically ill patients[10]. This technique consists of a 530-nm light source, a wavelength
that is absorbed by hemoglobin within erythrocytes, allowing for the viewing of flowing
cells in the sublingual vascular bed. The images obtained using SDF imaging can be
analyzed post capture to determine the severity of microvascular dysfunction. Briefly, the
images are separated into quadrants and capillaries are categorized based on RBC transit
to obtain a measure of perfusion quality. In addition, dividing the image by 3 vertical and
3 horizontal lines, and determining the number of vessels that cross these lines, is a
determinant of vessel density[34].
While SDF imaging has demonstrated correlations with severity in sepsis, it is not
without limitations. The measurements made using this technique illustrate the degree of
perfusion within the observed network; however, there has been no demonstrated ability
to extract oxygen saturation data within the perfused capillaries. Furthermore, the
technique is very sensitive to motion and pressure artifacts, and it is thus difficult to
observe the exact same network over a period of time[34]. Also, the wavelength of light
used in this technique does not allow for good contrast between the red blood cells and
the capillary lumen[11], which is subject to inter-observer variability due to qualitative
assessment of perfusion. The relevance of alterations in sublingual perfusion in a
heterogeneous disease state such as sepsis have not been shown to be a definitive
indicator of septic onset, and until more objective measurement tools are available,
should only act as a secondary marker of the progression of microvascular failure in
sepsis.
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1.4

Overview of Clinical Sepsis Diagnostic Criteria

One of the major challenges in diagnosing sepsis in global ICUs has been due to lack of a
precise definition of sepsis[6]. In addition, patients in the ICU often suffer from
comorbidities, which cause a largely heterogeneous array of symptoms.
Table 1-1 provides the criteria most commonly used to diagnose systemic inflammatory
response, and illustrates the flow of criteria used to identify sepsis.
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Diagnostic	
  Criteria	
  	
  

	
  

Systemic	
  Inflammatory	
  

Core	
  temperature	
  >38oC	
  or	
  <36oC	
  

Response	
  Syndrome	
  
(SIRS)	
  

Heart	
  rate	
  >	
  90	
  beats/min	
  
Respiratory	
  rate	
  >20	
  breaths/min	
  or	
  PaCO2	
  <32	
  mmHg	
  	
  
White	
   blood	
   cell	
   count	
   >	
   12,000	
   cells/mm3	
   or	
   <	
   4,000	
  
cells/mm3	
   or	
   differential	
   showing	
   10%	
   immature	
  
(band)	
  neutrophils	
  

Sepsis	
  :	
  2	
  or	
  more	
  of	
  SIRS	
  
+	
  proven/suspected	
  
infection	
  

Documented	
  infection	
  
Perforated	
  viscous	
  
Syndrome	
  associated	
  with	
  a	
  high	
  likelihood	
  of	
  infection	
  	
  

	
  

Bacteria	
  in	
  a	
  normally	
  sterile	
  fluid	
  

	
  

Evidence	
  of	
  pneumonia	
  with	
  purulent	
  sputum	
  

Severe	
  Sepsis:	
  	
  Sepsis	
  +	
  

Cardiovascular	
   –	
   Use	
   of	
   vasopressors	
   or	
   systolic	
   BP	
  

Evidence	
  of	
  organ	
  

<90mmHg	
  

dysfunction	
  	
  

resuscitation	
  

or	
  

MAP<70	
  

mmHg	
  

despite	
  

fluid	
  

Renal:	
  urine	
  output	
  <0.5ml/kg/hr	
  	
  
Respiratory:	
  mechanical	
  ventilation	
  or	
  PaO2/FiO2	
  <	
  250	
  
mmHg	
  
	
  

Hematologic:	
  platelet	
  count	
  <	
  80,000	
  cells/mm3	
  

Table 1-1 Criteria used to diagnose a septic patient [6, 8, 35]. This table illustrates
common physiological parameters that are used to diagnose a patient as septic.
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1.5

Early Goal-Directed Therapy in Sepsis

While there is difficulty in adequately defining sepsis, early recognition and associated
intervention is associated with improved survivability. The ability to recognize sepsis in
the early stages of the disease, when treatment would be most effective, is difficult. As
sepsis develops, hypovolemia, myocardial depression, increased metabolism and loss of
vasoregulation create an imbalance between oxygen supply and demand by the vital
organs[36]. Organ dysfunction quickly ensues, and if unrecognized, leads to increased
mortality in the early phase of septic onset[37].

Due to perturbations in systemic

circulation, the body is not able to match oxygen supply to demand, and attempts to
compensate by increasing oxygen extraction, which consequently leads to a decrease in
mixed venous oxygen. This in turn, leads to increased lactate production as the oxygen
extraction limit is reached, which is a hallmark of early sepsis. The early-phase
recognition of sepsis is the primary target of early goal-directed therapies aimed at
preventing the dysfunction cascade that progresses very rapidly once it is initiated.
The systemic parameters that are relied upon to diagnose sepsis in the early phase are
usually CVP, MAP, and lactate levels. The monitoring of these parameters is standard
practice in the clinical setting, and allows for early identification of patients at risk of
becoming septic. Early goal-directed therapy involves aggressive fluid resuscitation in an
attempt to increase intravascular volume, venous saturations, and to optimize systemic
hemodynamic parameters (CVP, MAP)[36]. It has been shown that fluid therapy in the
early phase of sepsis has a survival benefit, which is the reason that resuscitation is very
common, and identification of an ideal fluid for resuscitation is important[38]. The
drawback of early goal-directed therapy is that achievement of systemic targets does not
directly indicate restoration of the microcirculatory environment; oxygen delivery and
inflammation-mediated perfusion impairment may still persist, resulting in local tissue
hypoxia.

1.5.1 Resuscitation Fluids
The primary goal of resuscitation fluids and early goal-directed therapy is to restore the
intravascular volume of hypovolemic patients [39]. Choice of fluid type for resuscitation
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is highly debated amongst ICU physicians; however, early administration of fluids is
associated with decreased mortality[3]. Two of the most commonly used fluids for
resuscitation are saline and albumin, and there have been several studies and metaanalyses (SAFE, CRYCO, Delaney (Meta-analysis), Cochrane Group (Meta-Analysis))
that have attempted to determine which resuscitation fluid best improves mortality in
sepsis, to no avail[40-43]. One potential explanation of this consistent discrepancy is due
to the variability in patient recruitment within these clinical trials. The presence of comorbidities and the timing of sepsis diagnosis vary greatly in the ICU, which makes
interpreting the efficacy of resuscitation fluid inherently difficult.
Mechanistically, a bolus injection of fluid into the venous system for fluid resuscitation
takes advantage of the Frank-Starling mechanism, by increasing right arterial pressure,
leading to increased cardiac output. The bolus injection increases venous return by
increasing systemic pressure due to volume increase, which causes increased flow to the
right heart. In addition, the large volumes of fluid administered in resuscitation regimens
result in the hemodilution of the blood. This reduces the resistance of the blood in the
circulation due to slightly decreased viscosity, which is another reason that cardiac output
and venous return increase[44].
Physiologically, the main difference between albumin and saline is that albumin
generates colloid osmotic pressure (COP), or oncotic pressure, which is responsible for
drawing water into the vasculature. COP is inversely proportional to extravascular fluid
flux, thus maintaining intravascular volume[45]. Albumin is able to maintain COP due to
the Van’t Hoff’s equation:

𝑂𝑠𝑚𝑜𝑡𝑖𝑐  𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒   𝜋 =

𝑅𝑇𝑐
+ 𝑘𝑐 !
𝑀

(1)

Where R is the universal gas constant, T is the temperature, M is the molecular mass of
the substance, c is the concentration, and k is a constant. From this equation it can be
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deduced that osmotic pressure is proportional to concentration, and inversely proportional
to molecular mass. Albumin is the major contributor of oncotic pressure in the blood as it
has the smallest molecular weight (69kD) of all the plasma proteins, and it is the most
abundant. The osmotic effect of albumin is further increased by its negative charge,
which causes attraction of cationic molecules into the intravascular environment[46].
Saline on the other hand is not able to maintain osmotic pressure, and causes dilution of
the oncotic agents in the normal blood plasma. Thus saline resuscitation leads to
decreased COP, causing increased filtration of water across the capillary membrane. This
causes a greater increase in interstitial fluid than intravascular volume, and illustrates
why higher volumes of saline would be required to achieve the same degree of
intravascular volume expansion as albumin.
A comparison of physiological characteristics between 5% albumin and saline is
provided (Table 1-2). In addition to osmotic pressure, albumin has a number of
potentially protective roles, especially within compromised microvasculature. Albumin
decreases the permeability of the vasculature, and decreases the leakage of fluid by down
regulation of vascular inflammation. Though the exact mechanism is not known, the
negative charge of albumin may repel membrane proteins; the size of the albumin
molecules may reduce the size of endothelial pores thereby reducing vascular leak.
The protective effect of albumin is further supported by the finding that albumin plays a
role in preventing endothelial cell apoptosis which, when considering the microvascular
dysfunction associated with sepsis, may provide a survival benefit[47]. Albumin has
anticoagulant effects similar to heparin, and acts to lessen leukocyte-endothelial cell
interaction and platelet aggregation. Albumin also has binding capabilities, which allows
albumin to act as a carrier for antibiotics and many other potential therapeutics[46].
Hypoalbuminemia is associated with poor prognosis, and exogenous administration of
albumin has been found to produce a survival benefit in these patient cohorts. It remains
unknown whether the lack of albumin in these patients causes poor outcomes, or is
merely an indicator of a more severe issue[46].
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The drawbacks of albumin are that it is relatively expensive, and due to the fact that it is
created by pooled human plasma, has the potential to transmit infection. Furthermore,
there are some cohorts of patients, such as those present with traumatic brain injury, that
have significant increases in mortality with albumin resuscitation, such that albumin
resuscitation should be avoided in these cases.
The drawback of saline, besides a greater tendency for tissue edema, is the potential for
hyperchloremic metabolic acidosis. This is caused by an overall decrease in blood pH,
due to dilution of blood bicarbonate, which would be stimulated by the large amount of
saline required to achieve resuscitation targets. Hyperchloremic metabolic acidosis
caused by large volumes of saline resuscitation may cause increased inflammation and
mortality in sepsis[48].
Although in theory albumin appears that it would be more effective as a resuscitation
fluid, high-quality evidence supporting the beneficial effect of albumin is lacking[41].
The secondary aim of this thesis was to provide insight into the efficacy of albumin
versus saline as resuscitation fluids. While many different fluids are still used clinically,
the decision to begin with 5% human albumin and saline as the first application of our
model lies in the relevancy to global critical cares. In an animal model with a controlled
insult, the administration of bolus fluids was implemented in accordance with clinical
hemodynamic targets to maintain translational integrity.
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Colloid	
  

Crystalloid	
  

	
  

5%	
  Albumin	
  

0.9%	
  Saline	
  

69	
  

0.06	
  

COP,	
  mmHg	
  

20-‐30	
  

0	
  

Maximum	
   Volume	
   expansion,	
  

70-‐100	
  

20-‐25	
  

12-‐24	
  

1-‐4	
  

Low	
  

Low	
  

Molecular	
  

weight,	
  

Average	
  

(kD)	
  

%	
  
Duration	
  of	
  Volume	
  expansion,	
  
h	
  
Potential	
  for	
  adverse	
  reactions	
  
Possible	
  Side	
  Effects	
  
	
  	
  

Allergic	
  Reactions	
  
Transmitted	
  
Infection	
  

	
  	
  

Hyperchloremic	
  
acidosis	
  
	
  

Table 1-2 Comparison of physiological characteristics of the most commonly used
colloid and crystalloid fluids for resuscitation[45].

1.6

Animal Models of Sepsis

In critical care research, the importance of animal models that accurately mimic the
human septic condition is integral in the development of therapeutics, for the
development of sepsis staging criteria, and to broaden understanding of sepsis
pathophysiology[49]. The difficulty in carrying out effective research in humans lies in
the multitude of potentially confounding variables in recruited patient cohorts. The
presence of comorbidities (e.g. diabetes, pneumonia, myocardial infarction), various
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sources of initial infection, and concomitant therapeutic interventions, are all sources of
variability that impede valid conclusions within the clinical research environment[7].
Research difficulty is further exacerbated due to the fact that early diagnosis of sepsis is
based on unspecific criteria, and the progression from SIRS to sepsis can be caused by a
multitude of pathophysiological pathways[50].
Although it is difficult to perfectly replicate clinical sepsis, the ability to remove some of
the variability inherent to clinical human populations using an animal in a controlled
laboratory environment could be a valuable translational tool. Nevertheless, there is
currently a lack of clinically relevant animal models of sepsis[51]. This is a contributing
factor to the failure of so many clinical trials, and is a barrier to the development of
reliable therapeutics for the treatment of sepsis[7]. Animal models are necessary not only
in the development of therapeutics, but also in understanding mechanistically how the
therapeutics may improve patient outcomes and mortality rates [52]. There are several
fundamental issues with animal models of sepsis that make translating knowledge from
the bench to the bedside difficult they include: source of induced insult, lack of
physiological monitoring and intensive care, timing of treatment, lack of co-morbidities,
and animal type[7, 49, 51-53].
In an attempt to mimic the human septic condition, several animal models have been
developed, which can be categorized based on the type of initiated insult. The most
common infective agents are: exogenous administration of toxin (e.g. lipo-polysaccharide
(LPS)), exogenous pathogen administration (bacteria), and iii) endogenous disturbance of
protective barrier against bacteria (e.g. cecal ligation and perforation (CLP))[49]. While
each model has merits in terms of understanding response to infection, the ability to
mimic the hemodynamic response in septic patients is essential. The hemodynamic
response occurs in two distinct phases: the early phase (increased cardiac output, low
peripheral resistance) and the late phase of hemodynamic shock (decreased cardiac
output, low peripheral resistance[54]. Besides the disparity in immune response, both
exogenous toxemia and bacterial infection models are also unable to replicate the human
hemodynamic response, which limits the clinical applicability of these models. While
these methods are still commonly used, CLP is considered the gold standard, as this
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source of infection is able to effectively mimic the hemodynamic conditions attributed to
the human septic response[2]. A common criticism of animal models is the lack of
intervention that would ensue in a patient present with the same conditions. The CLP
model creates necrotic tissue, promoting abscess formation, which would necessitate
excision in a human patient[49]. The formation of an abscess is a further drawback of the
CLP model; an animal can stave off the infection, effectually preventing septic onset[2].
Furthermore, puncture size and amount of expressed fecal matter causes large variation in
severity of the infectious stimulus between animals, which decreases the consistency
necessary to draw effective conclusions from animal experimentation. These issues are
exacerbated by the lack of physiological monitoring to follow the overall status of the
animal, and for comparison to output from instrumentation common to ICU patients.
The lack of intensive care monitoring in animal studies is a major drawback in models of
sepsis. Septic patients are instrumented such that indicators of macrovascular data (MAP,
CVP, HR, Respiratory Rate) are continuously monitored, and mechanical ventilation is
usually necessary[52]. The lack of instrumentation, and thus absence of physiological
monitoring, is closely associated with inconsistency in interventional techniques. If
physiological data is not available, both sepsis diagnosis and therapeutic interventions are
not guided by the same criteria as the clinical setting[53]. This leads to arbitrary
implementation of interventions, potentially before the animal would be clinically
considered septic, and creates a further disconnect between the bench and the bedside.
The lack of co-morbidities in animal models is another common point of criticism. The
plethora of possible comorbidities in septic patients is misrepresented in animal models,
and is a very common criticism of translational research [7, 50-52]. While introducing
co-morbidities into an animal model may improve clinical relevancy, the potential for
confounding variables is large, and the choice of co-morbidity would still only represent
a small portion of septic patients. The use of a two-hit model in theory would provide
valuable information; however, a basic one-hit model needs to first be established in
order to distinguish the effect of the co-morbidity on the septic response. This is also true
of therapeutic interventions, higher-level instrumentation, and septic models with longer

16

durations (see Fig. 1-1). The primary aim of this thesis was to develop this central node
model that can act as a platform for future sepsis studies.
The use of animals, such as baboons, sheep and pigs is common to sepsis research;
however, the large cost of these experiments preclude their use in large numbers, which is
necessary to effectively establish the potential benefit in human patients. In addition to
cost, these large animals are less sensitive to bacteria than humans, thus posing a
challenge to translational research. Sheep models of sepsis have illustrated similar
sensitivity to humans, and replicate the hemodynamic response of sepsis; however, there
have been few survival studies in sheep, which limits the effectiveness of their use in
pharmacological research[51]. The use of murine models of sepsis has come into
question recently due to the discovery that the difference in genomic response to
inflammation is misrepresentative of the human condition[55]. Also, the small size of
mice, and low blood volume (~1ml/25g mouse) makes it difficult to fully instrument a
mouse to monitor global hemodynamic changes throughout sepsis, and regular blood
sampling is not possible. The larger size of rats, allows for a greater degree of
instrumentation, and the ability to obtain regular blood samples. Thus far the genomic
response of rats to septic insult has not been refuted, and based on experimental studies,
rats phenotypically mimic the hemodynamic changes associated with the human
response.
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Figure 1-1 The need for a basic translational animal model of sepsis. The establishment
of a central node model of sepsis is very important and would form a platform that can be
altered depending on desired clinical scenario, while maintaining the accuracy and
integrity of clinical practice. The formulation of this node model is of fundamental
importance for global critical care research.
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1.6.1 Design Constraints for a New Sepsis Model
Given the rationale for a model of sepsis that is more relevant to the clinical scenario, the
aspects that need to be incorporated in order to be effective relate to macrovascular
measurements, a window into the microvascular environment, controlled insult, and
clinical diagnostic criteria.
Instrumentation that is able to provide systemic data over the entire course of the septic
response, from implementation of insult to the culmination of the experiment, is essential.
Choosing an appropriately sized animal to allow for a high degree of instrumentation,
with minimal invasiveness is a primary first step. The instrumentation should provide
basic vital sign data (MAP, CVP, HR, and Respiratory Rate), for the duration of the
experiment. Additional instrumentation will only strength the translational application of
the developed model, and will allow for a more complete representation of systemic
parameters, increasing the validity of experimental findings.
Next, a window into the microvascular environment is important to be able to determine
the effect that macrovascular perturbations have on the systemic microcirculation. As
capillaries are the primary area for gas exchange to tissue, the ability to monitor perfusion
alterations over the course of a septic insult is integral to providing clinically relevant
data. As qualitative measurements are relied upon clinically, the added ability to make
quantitative microvascular measurements may provide mechanistic explanations for
clinical observations. Furthermore, the window into the microvasculature brings a twosided approach to septic animal research, allowing for more accurate interpretation of
results.
The ability to control the insult between animals is also important to be able to replicate
the septic response. A major issue in elucidating information clinically is due to the
variety of patient backgrounds and differing degrees of sepsis severity. For this reason,
mimicking the response between animals, and in essence, between treatment groups,
allows the data extracted to be attributed to interventional therapies, and modifications to
the model, rather than due to variability in the initial insult.
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Lastly, and most often overlooked is the necessity to monitor the animal after the
initiation of insult, and to only intervene when the animal would be clinically diagnosed
as septic. This prevents the animal from being “pre-treated” before the onset of sepsis,
which could greatly improve survivability, and potentiate misleading conclusions.

1.7

Objectives and Hypotheses

This thesis involved two main objectives:
1) To create an animal model of sepsis, incorporating the rationale for an effective
translational model
With the guidance of critical care physicians we aimed to create an animal ICU, for the
instrumentation of an animal that can be monitored as a human surrogate. We aimed to
monitor the physiological parameters over the entire course of the septic response, and to
develop an insult that would mimic the cardiovascular events of human sepsis. We also
wanted to ensure that our insult was sufficient to create an obvious sepsis diagnostic
window that would be related to clinical indicators of early sepsis. Lastly we wanted to
incorporate the use of a microvascular window in an organ remote the site of initial
inflammation in order to assess the degree of microvascular dysfunction associated with
our administration of the septic insult.
2) To test the application of our model by testing the efficacy of different fluid types for
clinical hemodynamic optimization, and the associated effect on the microvascular
environment
We decided to test the two most common resuscitation fluids saline and albumin, due to
the debate as to which fluid better restores systemic homeostasis and improves
survivability. As there is not a well-defined way to measure microvascular perfusion
quantitatively, mortality, and global systemic parameters are relied upon for
determination of fluid efficacy. The application of our model to test this issue permits
two-sided data acquisition, allowing for the characterization of fluids based not only on
global hemodynamic targets, but also on the ability to prevent/restore microvascular
perfusion. Our goal was to test the efficacy of saline and albumin as resuscitation fluids
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with respect to optimization of hemodynamic parameters at the macrovascular level, and
restoration of microvascular perfusion.
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Chapter 2
Developing a translational animal model of sepsis
2.1

Introduction

Despite global research efforts aimed at improving outcomes in sepsis, the associated
systemic inflammatory response and multiple organ failure remains the major cause of
mortality and morbidity [1]. Although understanding of the pathophysiology of sepsis is
improving, translating the pre-clinical knowledge of sepsis from the bench to the bedside
remains a major challenge[2]. A recent international roundtable discussion aimed at
improving clinical trials in the critically ill emphasized the need for a translational animal
model of sepsis that is more representative of the clinical scenario[3]. The discussion was
spawned by the failure of over 60 randomized clinical trials, citing the shortcomings of
previously developed animal models as a major contributing factor. The main issue
reported in this article is that many animal models fail to consider the physiological status
of the animal over the entire course of a septic insult. The lack of a clinically relevant
animal model of sepsis is a major obstacle in terms of developing effective therapies for
sepsis[4].The failure to use a clinical definition of sepsis to initiate potential therapies
may also cause misleading conclusions, and thus ineffective translational research. In
addition, the authors noted that it is important to be able to tightly control an
experimental system, especially in a heterogeneous disease state such as sepsis. For this
reason, it is important to choose an animal type, and a route of induced infection that will
adequately and consistently mimic the human septic response[4-6].
In terms of replicating human sepsis, it is common to divide the response into two phases:
early and late sepsis. Early sepsis is often characterized by an increase in cardiac output,
and low peripheral resistance, whereas late sepsis involves low cardiac output, while still
exhibiting low peripheral resistance[5]. The difficulty representing the early phase of
sepsis in an animal model can be attributed to early goal-directed therapies in the clinical
treatment of septic patients. Clinically, in the early phase of sepsis, a patient has likely
already received antibiotic and fluid therapy, inducing a hyperdynamic circulatory state.
As previously mentioned, in creating a clinically relevant animal model of sepsis, it is
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important to illustrate the baseline effect of a septic response prior to intervention
implementation. For this reason, short-term animal models of sepsis prior to any
interventions are more likely to represent the transition from “pre-sepsis” to early phase
sepsis, which is commonly associated with a drop in cardiac output, and an increase in
peripheral resistance[7, 8]. Representing this transition phase is important in terms of
elucidating the mechanistic effect of early-goal directed therapies implemented at the
time of diagnosis of sepsis. Clinically, peritonitis represents 20-25% of infections leading
to severe sepsis[9]. Several rat models of septic peritonitis have been established, and the
response to infection is well documented and understood. For these reasons, the use of a
peritonitis-based insult serves as a strong foundation for the development of a consistent
and comprehensive model of clinical sepsis[7, 8, 10, 11].
The goal of our study was to create an animal model of sepsis, which involved clinical
experience from ICU physicians in an effort to create a platform that promotes effective
translational research. Considering recommendations from the international roundtable
discussion, as well as input from the Canadian Critical Care Translational Research
Group, we created a clinically relevant model that closely resembles nosocomial sepsis.
We present a two-sided approach in the creation of our model in that we have the unique
ability to measure both macrovascular and microvascular parameters over the entire
course of a septic response. Intensivists, to ensure clinical accuracy, guided our novel
approach and the associated diagnostic and instrumentation protocols. Our use of a flow
probe on the abdominal aorta, as well as a pulse transducer catheter in both the carotid
artery and jugular vein allow us to accurately measure CO, MAP, HR, and CVP for the
entire course of our experiment. This high level of instrumentation allows us to
accurately calculate peripheral resistance, and stroke volume without relying on observer
tracings of aortic diameters[12].
Additionally, we use dual-wavelength intra-vital video microscopy (DλIVVM) to observe
the microculation in the hindlimb muscle of our animals. Utilizing the differing light
absorption properties of oxy- and deoxyhemoglobin we are able to elucidate the oxygen
saturation changes over the course of a septic insult. This measurement technique is
valuable for validation of our model as we are able to monitor macrovascular and
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microvascular changes from “pre-sepsis” to early sepsis [13, 14]. A detailed diagram
illustrating the parallels of our animal model, and a patient in the ICU is provided (Fig. 21).
This model will act as a stepping-stone for future studies, and can be easily adapted to
match the ever-evolving demands of critical care research. The aim of this paper is to
illustrate the capabilities of our animal model by demonstrating our instrumentation, data
collection, and analysis techniques.
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Figure 2-1 Parallels between instrumentation of a human patient in the ICU, and our
animal model. Human heart rate is measured using an electrocardiograph; cardiac output
is measured using the thermodilution technique via a Swan-Ganz catheter implanted into
the pulmonary artery, microcirculation is qualitatively assessed using side-stream dark
field imaging. Animal model instrumentation is described in the methods.
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2.2

Materials and Methods

Animal protocols were approved by the Animal Care and Use Committee of the
University of Western Ontario (see appendix A). Sprague-Dawley rats were used in this
study; male rats were used exclusively in order to eliminate the effects of the estrous
cycle[15].

2.2.1 Animal Instrumentation
The rats (100g on delivery) were housed in the animal quarters at the University of
Western Ontario and acclimatized for 7 days after delivery. On the day of the experiment
rats were randomized to FIP or sham laparotomy groups, and weighed to verify that their
mass was within experimental range (170-210g). Animals were anesthetized via
intraperitoneal injection of sodium pentobarbital (6.5 mg/100g body weight). A rectal
thermometer was inserted to monitor temperature, and a heat lamp was used to maintain a
core body temperature of 37oC.The trachea was cannulated to allow mechanical
ventilation at a rate of 73-76 breaths/min with a flow-controlled air mixture of
30%O2/70%N2. The left common carotid artery was cannulated with polyethylene tubing
(I.D. 0.58mm, O.D.0.965mm). The carotid artery cannula allowed heart rate and mean
arterial pressure to be monitored and recorded via the amplified signal of an attached
pressure transducer and PowerLab system (model ML118 PowerLab Quad Bridge
Amplifier; model MLT0699 BP Transducer, ADInstruments, Colorado Springs, CO,
USA). The right external jugular vein was cannulated using Silastic tubing (I.D.0.64mm,
O.D. 1.19mm) with a beveled end through which saline (0.9%) was continuously infused
for minimal fluid resuscitation (0.5 ml saline/h). Supplemental doses of anesthetic were
delivered via the jugular catheter as needed to maintain sufficient anesthesia for the
duration of the experiment (7 hours). The jugular vein cannula allowed central venous
pressure to be monitored and recorded via the amplified signal of an attached pressure
transducer and associated software (Digi-Med LPA-400, DMSI-200 host software,
Micro-Med, Louisville, KY). A Transonic perivascular flow probe cuff (2mm, model
2PSB) was placed on the abdominal aorta between the right iliolumbar artery and the
right external iliac artery. The flow probe allowed cardiac output to be continuously
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monitored and recorded via the PowerLab system. The incision was then sutured closed
in two layers.
The extensor digitorum longus (EDL) muscle was blunt dissected and externalized as
previously described[16]. Briefly, a small section of skin was excised from the lateral
side of the right hindlimb in order to expose the underlying fascia capsule. Superficial
dissection of the capsule and blunt separation of the surrounding muscle allowed the EDL
to be separated from the surrounding muscle tissues. Once isolated, silk ligature was
threaded beneath both the intact muscle, and the attached distal portion of the EDL
tendon and secured with a square knot. The tendon was severed between the knot and
EDL muscle insertion, leaving the ligature securely attached to the free end of the EDL
tendon. After EDL dissection, the animal was transferred to the microscope stage and
placed in a supine position. The midline stitches were removed, and peritonitis was
induced via intraperitoneal injection of autologous feces (FIP) (0.3 ml/100g rat of fecal
slurry (1.5g feces in 1.5 ml saline)). The FIP slurry was made fresh prior to the start of
instrumentation. The sham procedure consisted of removing the midline stiches, and
injection of mock-FIP (0.3 ml/100g saline) into the abdominal cavity. See Appendix C.
The incision was then sutured closed in two layers and the animal placed in the right
lateral decubitus position. The ligature attached to the EDL tendon was placed on the
microscope stage such that the lateral side of the muscle faced the objective lenses. The
ligature was then taped to maintain a length and angle approximate to the in situ position
of the muscle. The muscle was moistened with 37°C saline (0.9%) and covered on the
medial side with a small rectangle of plastic film (2 1 cm, polyvinylidene chloride, Saran)
and a glass coverslip sealed with vacuum grease to isolate the muscle from the external
environment.

2.2.2 Dual Wavelength Intra-Vital Video Microscopy
The acquisition system was composed of an Olympus IX81 inverted microscope
(Olympus objective X20/0.75 numerical aperture) fitted with a 75W xenon lamp to
transilluminate the muscle, a beamsplitter (Photometrics-DC2) with a filter cube
containing interference filters at wavelengths 442-nm and 454-nm, and two Q-Imaging
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Rolera-XR digital video cameras attached to the beamsplitter. Adjustments on the beam
splitter made it possible to register the two images and make them parfocal for
simultaneous video capture at the two wavelengths. After allowing the muscle to
equilibrate (30 minutes) real-time microvascular blood flow video sequences (696 X 520,
21 frames/second) were taken of in-focus capillaries within the EDL muscle. The videos
captured at the wavelengths (442-nm and 454-nm) were chosen to utilize the unique
light-absorption properties of oxy- and deoxyhemoglobin similar to the previously
described system[17]. The 454-nm wavelength is an isosbestic wavelength, whereas
absorption at the 442-nm wavelength changes with oxygen saturation.

2.3

Experimental Protocol

2.3.1 Video Recordings
After the intraperitoneal injection (baseline), the physiological status of the animal was
continuously monitored, as previously outlined. Microvascular blood flow video
sequences were taken of in-focus capillaries in 10 distinct fields of view. Recordings
were made at baseline (after equilibration), 3 hours, and 5 hours post-injection.

2.3.2 Blood Samples
After the video sequences were recorded 250μl of heparinized arterial blood was
collected (baseline, 3, 5 hours). Once the sample was collected the blood volume was
replaced with heparinized saline. To measure systemic blood variables, an iSTAT pointof-care system was used, along with associated cartridges (CG4+: Lactate, blood gases,
CG8+: Na, K, iCa, Gluc, Hct, blood gases).
A timeline representation of the above methodology is provided (Fig. 2-2).
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Figure 2-2 Timeline of study for animal model. Blue arrows indicate the timing of video
captures, as well as timing of blood collection. Red asterisk indicates administration of
FIP, and BL indicates the timing of baseline measurement collection. The animal is
minimally resuscitated with an infusion of saline (0.9%, 0.5 ml/hr). MAP, HR, CVP, and
CO are measured for the entire observation period.

2.3.3 Video Processing and Functional Images
At the culmination of the experiment, the recorded video sequences were processed and
stored as uncompressed 16-bit PNG files using custom capture software (Neovision). The
video sequences from both wavelengths were processed using Matlab algorithms, as
previously described, which produce functional images[18]. These images allowed
delineation of hemodynamic and O2 saturation measurements for individual capillaries,
using custom software developed in our lab. Briefly, the functional images allow the
software to accurately determine the coordinates of the lumen of the selected capillaries,
as well as the centerline of the vessel. Once the vessel is traced, light intensity levels
along the centerline of the vessel are extracted over the sample interval producing spacetime images (STIs), one for each wavelength. Measurement of average velocity, O2
saturation, RBC supply rate, hematocrit, and diameter were made from the analysis of the
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STIs. All in-focus vessels, from each field of view, at each timepoint, were analyzed
using the same technique. A total of 16 in focus capillaries were analyzed in the hindlimb
muscle of the presented animal. See Appendix B.

2.3.4 Functional Capillary Density Measurement
Capillary densities were determined from the captured video sequences by counting the
number of capillaries that crossed three staggered overlaid test lines (200μm	
   each)	
  
perpendicular to the direction of the EDL muscle fibers	
   as	
   described	
   previously[14]. A
total of three staggered test lines were overlaid for each recorded field perpendicular to
the direction of the EDL muscle fibers. The capillaries that intersected the test line were
categorized over a 30 second interval based on the degree of RBC transit as either:
continuous, intermittent, or stopped. A capillary was considered continuous if the flow
was uninterrupted over the sequence, intermittent if flow had at least 3 seconds of
stopped flow, or had a period of reversed flow direction, or stopped if the capillaries did
not have any flow over the course of the recorded video sequence. Capillaries that did not
have RBC’s were not included in capillary density measurement. Capillary density was
counted for each field of view, at each time point, and averaged to determine the change
in capillary density over the course of the septic response. In the presented data, 10 fields
of view were measured to determine functional capillary density.

2.3.5 Physiological Data Analysis
The physiological data collected for the duration of the experiment were analyzed using
LabChart software. A moving average was used to analyze the collected variable signals
(MAP, CVP, CO, HR). A 300 second (5 minute) averaging window was chosen, and the
average of each interval was taken over the course of the experiment (5 Hours). This was
done to eliminate major deviations within the signal in order to extract the physiological
effect of the insult alone. Stroke volume (CO x HR) and total peripheral resistance
(MAP-CVP/CO) were calculated at the culmination of the experiment.
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2.3.6 Physiological Variables
The clinical adaptability of our model lies in the parameters we can continuously
monitor. Comparing the microvascular data to the macrovascular data facilitates a better
understanding of the underlying pathophysiology of the septic response.

2.3.7 Statistical Analysis
Microvascular data and functional capillary density measurements are presented as mean
and standard deviation. The data presented are for one (n=1) demonstration animal, thus
analysis for statistical significance was not performed.

2.4

Results

2.4.1 Animals
Examples of arterial blood measurements from a single septic animal demonstrating the
global measurements collected over the course of a septic insult are found in Table 2-1.
The systemic parameters were measured at 3 time points to track the progression over the
course of the experiment.
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Hct	
  (%)	
  

Lactate	
  (mmol/L)	
  

Glucose	
  (mmol/L)	
  

Baseline	
  

0.43	
  

1.51	
  

10.3	
  

3	
  Hours	
  

0.45	
  

1.06	
  

9.4	
  

5	
  Hours	
  

0.46	
  

2.7	
  

3.2	
  

	
  

pH	
  

pCO2	
  
(mmHg)	
  

pO2	
  (mmHg)	
  

Baseline	
  

7.438	
  

37.9	
  

113	
  

3	
  Hours	
  

7.437	
  

34.1	
  

128	
  

5	
  Hours	
  

7.353	
  

38.6	
  

108	
  

Table 2-1 Systemic variables at baseline, 3 hours, and 5 hours. All measurements were
made from heparinized arterial blood collection, immediately following video capture.
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Figure 2-3 Macrovascular measurements from baseline to 5 hours post insult of (A)
Heart Rate (B) MAP (C) Cardiac Output (D) CVP, (E) Stroke Volume* and (F) Total
Peripheral Resistance* (n=1). The superimposed line on the blood pressure graph
indicates clinical sepsis inclusion criteria (<75mmHg). See Appendix C. In this example,
our diagnosis of sepsis occurs around the 3.5-hour timepoint. * = Calculated

37

Figure 2-4 Microvascular quantification of capillary A) Oxygen Saturation, B)
Hematocrit, C) Velocity and D) Supply rate (n=16 capillaries).
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Figure 2-5 Functional capillary density for baseline, 3-hour and 5-hour time points to
quantitatively measure the degree of microvascular dysfunction. Analyzed capillaries are
categorized as either continuous flow, intermittent flow, or stopped flow capillaries based
on degree of RBC transit. Values correspond to the number of capillaries in each
category that cross the 600-µm test line. (n=10 fields of view)
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2.5

Discussion

This study presents a novel model of sepsis that is more clinically relevant, as the high
degree of instrumentation provides continuous macrovascular data, while concurrently
providing a window of the microvasculature to assess the degree of dysfunction.
Furthermore, our use of FIP to induce sepsis allowed us to obtain systemic measurements
immediately following the initiation of insult (true baseline). The success of translating
animal studies to the bedside depends on the ability to effectively document the severity
of sepsis at the time of intervention. One of the main pitfalls of translational animal
research is the inability to monitor the septic response over the entire course of the
experiment. Thus our dual-sided approach addresses the major drawbacks of previous
animal models, and will ultimately provide insight into the mechanistic effects of
interventional therapies.
Clinically the efficacy of a treatment intervention will be affected by the severity of the
insult. Thus the information provided by the microcirculation is integral to determining
the severity of sepsis as it relates to the severity of dysfunction of the vital organs.
Currently, the sublingual microcirculation is the only easily accessible clinical
microcirculation that is used in an attempt to quantify changes in the microcirculation in
response to sepsis. While this technique provides qualitative information regarding
microcirculatory dysfunction, due to inherent technical limitations it is not currently
possible to make oxygen saturation measurements, and thus provides little insight into the
degree of oxygen delivery to tissues. For this reason, the microcirculatory window in our
model provides valuable information that allows determination of indices of oxygen
delivery to the tissues. It is our hypothesis that severity of organ dysfunction of sepsis
relates to the inability to deliver adequate oxygen to the organ tissues as a result of
microcirculatory dysfunction.
In terms of the recommendations from the roundtable discussion, the challenge of animal
models lies in the difficulty in representing the complexity of clinical sepsis, alluding to
the absence of models that focus on co-morbidities. Our model is a fundamental first step
towards addressing this problem. It is of critical importance when developing a model of
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human disease to have control over the entire protocol. The establishment of a reliable
foundation increases the adaptability of the model, and provides a workable baseline such
that the effect of modifications will be easy to detect. For example, with our established
model, using an aged animal would not require any modifications to our protocol, and the
effect of age on macrovascular and microvascular response to sepsis can be clearly
defined. In addition, our model does represent a simple two-hit model, as the surgical
procedure in instrumenting the animal requires invasive surgery. The surgical aspect of
our protocol, however, is minimal and therefore more predictable in terms of
inflammatory response of the animal (due to surgery). Taken together with the addition of
a septic insult, our model effectively represents clinical nosocomial sepsis arising
secondary to an initial trauma.
Utilizing FIP to induce sepsis also has distinct advantages over the use of endotoxin
administration or cecal ligation methods. Firstly, although CLP is considered the “gold
standard” in sepsis research, the procedure still introduces an inflammatory response
within the peritoneum, which can be variable depending upon the degree of fecal
contamination at the time of surgery, and whether or not abscess formation ensues [19].
The surgical process of ligating the cecum also takes considerable time, and delays data
acquisition to the extent that “baseline” measurements may be obtained up to an hour
after the initial insult (see Appendix C). Further, the inflammatory responses to intraabdominal abscess may also be variable which is dependent upon ability to contain the
infected area. While the size or number of punctures can somewhat control animal
mortality, the variability of fecal contamination is the major source of variability in the
severity of the insult between animals[5]. The use of the FIP technique introduces a
higher level of control, as the dose can be adjusted depending on the desired severity of
insult. In addition, the use of autologous fecal matter provides a similar type of insult to
that of a CLP without the creation of an additional inflammatory response from the
surgical intervention. Furthermore, it also mimics a clinical scenario of fecal
contamination of the peritoneum following gut perforation.
Another recommendation of the roundtable is that animal models provide insight into the
mechanism of action of targeted therapeutics. In order to better predict the response of
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septic patient to therapies, in vivo demonstration of physiological responses to an
intervention is imperative. Once again our model is able to successfully address this
concern due to our two-sided approach and the introduction of a true baseline in a septic
animal model. As therapeutics are often given based on a patient fulfilling distinct
inclusion criteria, the degree of instrumentation in our model would allow us to treat our
septic animals in the same fashion. The development of our model was driven by ICU
physicians in order to ensure that the future applications of this model to treatment
strategies have significant clinical representation. Besides the macrovascular data, the
concomitant microvascular information our model provides is of utmost importance.
While many clinical therapeutics target macrovascular endpoints, knowing the associated
effect on the microvasculature can provide valuable mechanistic information. For
example, fluid resuscitation strategies generally target MAP as an endpoint; however, it is
still unknown what macrovascular targets are the best predictors of improving oxygen
delivery to the microcirculation and if implementing microvascular endpoints of various
therapies may augment survivability. The demonstration animal in this study was
minimally resuscitated (0.5 ml/saline/hr) in order to illustrate the macrovascular effect of
the septic insult exclusively without the addition of fluid therapy.
The absence of continuous flow vessels at the 5-hour time point in figure 2-5 does not
affect our ability to make velocity and oxygen saturation measurements post experiment.
The processing software only requires that there is flow in the vessel at some point during
the video capture sequence. For this reason data can be extracted from intermittent flow
vessels even though they may have periods of stopped or reversed flow.
As closely as we have represented the clinical scenario, however, there are limitations
and potential additions that could improve the integrity of our model. In this model, we
rely upon MAP to indicate septic onset, as we already have a documented source of
infection; however, there are several other metrics utilized clinically that we are unable to
measure in our model. Firstly, urine output is commonly used to assess adequacy of fluid
resuscitation and to some degree, kidney dysfunction, which is a common indicator of
early sepsis. While it is possible to catheterize a rat, the technique is far more invasive
and complex than the same process in a human patient. Furthermore, the use of
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pentobarbital anesthetic suppresses the central nervous system, preventing passive
urinary flow. Due to the already invasive nature of our protocol, we chose not to
catheterize the bladder; however we could adapt our protocol to include this measurement
in the future. See Appendix C. Additional criteria that are used in diagnosis of clinical
sepsis include heart rate, and timing before requirement of mechanical ventilation. Our
choice of pentobarbital anesthetic requires mechanical ventilation early on in the surgical
procedure, prior to administration of the septic insult. While other anesthetics more
readily promote natural breathing, which would allow us to include time until mechanical
ventilation requirement, pentobarbital has the least interfering effect on the
cardiovascular parameters that are a strength of our model[20]. Furthermore, heart rate >
90 bpm is used clinically as an indicator of early sepsis. It is difficult to use rat heart rate
as a reliable indicator of sepsis as the heart rate of a rat is 6 to 7 times greater than that of
a human, and there is a large amount of innate variability in the heart rate signal. For this
reason we do not use heart rate as an indicator of systemic sepsis. Next, we present an
acute model of sepsis in that the septic response we instigate is monitored for 5 hours.
While the ability to completely mimic a human septic response would last several days,
our microcirculatory preparation is terminal. In order to completely duplicate the timing
of a human response we would have to sacrifice our microcirculatory data collection,
which is a pivotal advantage our model has over previous animal models.
In terms of adding to our model, harvesting the vital organs at the culmination of our
experiment could identify markers and pathological injury of sepsis, and would act to
bolster the relevance of our model to the clinical scenario. Next, measuring white blood
cell count, platelet, and creatinine levels would be a simple addition that would improve
the clinical relevancy of our model. Lastly, utilizing other techniques, such as nearinfrared spectroscopy, to assess the microvascular environment surrounding easily
accessible vital organs (brain, kidney etc.), would reinforce our use of the EDL as
representative vital organ vasculature.
In summary, our model presents a valuable tool in translational research, with an
abundance of potential applications. The model has many moving parts that can easily be
modified to meet the demands of critical care, and sepsis researchers alike. The model
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also serves as a valuable learning tool for clinicians with our unique ability to illustrate
the systemic affect of therapeutic interventions.

2.6

Conclusion

The presented model achieved our goal of creating a translational animal model, guided
by ICU physicians, that is representative of a clinical septic response. In addressing the
recommendations of the international roundtable discussion on animal research in sepsis,
we created a well-defined, repeatable model with a high level of control over the severity
of insult. This model lays the groundwork for future studies aimed at elucidating the
effects of interventional techniques such as fluid resuscitation, and impact of early goaldirected therapies on the microvascular environment.
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Chapter 3
Assessing fluid resuscitation efficacy in a translational
animal model of sepsis
3.1

Introduction

The systemic inflammation induced by sepsis poses significant challenges to the
circulatory system and causes local regions of hypoxia in the vital organs[1]. The fast
progression of this disease is associated with the imbalance between oxygen delivery and
oxygen demand, which leads to multiple organ failure, and high mortality rates in the
ICU[2]. The imbalance is due to a multitude of circulatory effects including
hypovolemia, myocardial depression, peripheral vasodilation, and increased tissue
metabolism[3]. It is well established that early recognition of sepsis leads to better
clinical outcomes, and improved survivability[4]. Early goal-directed therapy guided by
physiological targets is fundamental to improving patient outcomes, and administration
of fluids for resuscitation is often the first strategy to be implemented[3]. As of yet, there
is no “gold standard” fluid used for resuscitation, and there is constant debate among
clinicians as to which type of fluid best restores macrovascular and microvascular
targets[5]. Saline and albumin, two of the most commonly used resuscitation fluids, are at
the center of this debate. Several clinical trials and meta-analyses have attempted to
demonstrate conclusive evidence of an ideal resuscitation fluid; however, the findings,
much like the opinions of clinicians, were mixed[6-8]. While clinical trials and metaanalyses are able to involve large cohorts of patients, there are several sources of
variability inherent to patient recruitment that make it difficult to draw definitive
conclusions. Variability in patient background, concomitant therapies, timing of sepsis
diagnosis, and timing of intervention, all contribute to these discrepancies[9]. For this
reason, elucidating the actual mechanistic effect of fluid type on resuscitation is
intrinsically difficult. Furthermore, although fluid resuscitation strategies often target
global hemodynamic parameters, the mortality rate of sepsis remains relatively stagnant.
Recently, it has been shown that the macrocirculation and the microcirculation may be
differentially regulated in sepsis, which further demonstrates the need for considering the
effect of early goal-directed therapies on the microcirculatory environment[10-12]. The
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lack of evidence of fluid efficacy using translational animal models of sepsis only
exacerbates these pitfalls, defining a clear disconnect between the bench and the bedside.
Using our previously developed animal model of sepsis we are able to test the effect of
fluid administration on both the macrovascular and microvascular environment, over the
entire course of a septic response. In active collaboration with the Canadian Critical Care
Translational Research Group, and awareness of the PRECISE study, we decided to test
the effect of the most common resuscitation fluids: 0.9% saline, and 5% albumin[13].
There are currently no clinical guidelines that determine the use of one resuscitation fluid
over the other, thus comparing the efficacy of each fluid is a reasonable first application
of our model.
Saline is the most commonly used resuscitation fluid. Its purpose is to increase or
maintain vascular volume, however saline does not have the ability to maintain osmotic
pressure, and readily leaks into the extravascular environment. For this reason, a higher
volume of saline is generally required to maintain hemodynamic optimization[14].
We used 5% human albumin in accordance with common clinical concentrations.
Albumin is used as a resuscitation fluid since it maintains colloid osmotic pressure
(COP), which limits extravascular leakage[15]. Albumin also has anti-inflammatory
properties, prevents platelet aggregation, and may play a role in maintenance of
endothelial cell function[16].
The goal of this study was to utilize clinically relevant hemodynamic optimization
targets, in conjunction with our previously developed translational animal model of
sepsis, to determine the macrovascular and microvascular consequence of saline and
albumin as resuscitation fluids. We utilize dual wavelength intra-vital video microscopy
(DλIVVM) to provide a window into the microvasculature, in an organ remote to the site
of septic insult, that allows us to monitor the progression of microvascular dysfunction at
the onset of sepsis. This gives us the unique ability, in conjunction with a fully
instrumented animal, to provide physiological data similar to a patient in the ICU, with
the addition of a quantitative measurement of microvascular perfusion and oxygen
transport. While the sublingual microcirculation is relied upon clinically to assess
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microvascular perfusion, the measurement process is semi-quantitative at best and is
subject to many shortcomings that make bedside assessment in a critical care
environment fundamentally difficult[17]. Our novel approach provides accurate
measurements of oxygen saturation, velocity, supply rate, and hematocrit of RBCs
passing through single capillaries in the microvascular network. While we are able to
utilize scoring criteria to provide data similar to sublingual measurements, incorporating
RBC saturations into our sepsis model elucidates a true mechanistic effect of fluid
administration on tissue oxygenation, which greatly increases the translational ability of
our approach.
This paper presents preliminary results of our study investigating the effect of fluid type
on optimizing clinical hemodynamic targets, while concurrently providing insight into
the restorative ability of each fluid on the degree of microvascular dysfunction. We report
for the first time that after induction of sepsis, using a MAP of 75mmHg as our
resuscitation target, bolus injections of 5% albumin appear to better restore
macrovascular and microvascular parameters, compared to saline. Despite the ability to
restore MAP, saline had little effect on both cardiac output and microcirculatory
perfusion, with endpoints similar to our septic control animals. These preliminary data
suggest that albumin, administered at the onset of sepsis, is a more effective resuscitation
fluid in terms of hemodynamic optimization and, in-line with the emerging clinical goal
of microvascular restoration, may provide a protective effect in reducing the hypoxic
environment in the vital organs.

3.2

Methods

Animal protocols were approved by the Animal Care and Use Committee of the
University of Western Ontario (see appendix A). Sprague-Dawley rats were used in this
study; male rats were used exclusively in order to eliminate the effects of the estrous
cycle[18].
A timeline of the experimental protocol is provided (Fig. 3-1).
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3.2.1 Feces Induced Peritonitis (FIP)
Peritonitis was induced via intraperitoneal injection of autologous feces (FIP) (0.3
ml/100g rat of fecal slurry (1.5g feces in 1.5 ml saline)). The fecal slurry was made on the
day of the experiment. Sham animals received saline (0.3ml/100g rat, 0.9% saline) as
opposed to FIP slurry.

3.2.2 Animal Instrumentation
The rats (100g on delivery) were housed in the animal quarters at the University of
Western Ontario and acclimatized for 7 days after delivery. For these experiments we
used our previously developed translational animal model of sepsis. Briefly, on the day of
the experiment, rats were randomized to FIP, FIP-Saline resuscitated (0.9% Saline,
B.Braun Medical Inc., Irving, CA), FIP-Albumin resuscitated (Alburex 5, CSL Behring,
Ottawa, ON), or sham laparotomy groups, and weighed to verify that their mass was
within experimental range (170-210g). Animals were anesthetized via intraperitoneal
injection of sodium pentobarbital (6.5 mg/100g body weight), and mechanically
ventilated at a rate of 73-76 breaths/min with a flow-controlled air mixture of
30%O2/70%N2. Temperature was monitored using a rectal probe, and maintained at
37oC. The right carotid artery, and left jugular vein were cannulated to monitor heart rate
and MAP, and CVP respectively, via attached pulse transducers. Supplementary
anesthetic, and saline were administered via the jugular catheter, as needed. The bolus
injection of fluids was also administered via the jugular catheter, as required to maintain
clinical optimization targets. Cardiac output was measured using a transonic flow probe
attached to the abdominal aorta between the right iliolumbar artery and the right external
iliac artery. The incision was then sutured closed in two layers.
The extensor digitorum longus (EDL) muscle was blunt dissected as previously
described[19], and reflected onto the stage of a dual-wavelength intra vital video
microscope. Midline stitches were then removed and peritonitis was induced with an
intraperitoneal FIP injection. The sham animals received the same volume of saline. The
muscle was then secured via attached silk ligature at its in situ length, and relative
orientation, and was isolated from room air using a small rectangle of plastic film (2 x 1
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cm, polyvinylidene chloride, Saran) The muscle was moistened with 37°C saline (0.9%)
and a glass coverslip sealed with vacuum grease to isolate the muscle from the external
environment.

3.2.3 Dual Wavelength Intra-Vital Video Microscopy
The acquisition system was an inverted microscope fitted with a xenon lamp for
transillumination. A beam splitter with a filter cube containing interference filters at
wavelengths of 442-nm and 454-nm, which allowed for dual-wavelength video capture.
After allowing the muscle to equilibrate (30 minutes) real-time microvascular blood flow
video sequences (696 X 520, 21 frames/second) were taken of in-focus capillaries within
the EDL muscle. Post-processing using the dual wavelength system permitted calculation
of RBC velocity, supply rate, hematocrit, hematocrit, and oxygen saturations, of the infocus capillaries within the EDL muscle as previously described[20, 21].

3.2.4 Clinical Hemodynamic Optimization Target
The hemodynamic optimization target that we used for our study was motivated by
clinical inclusion criteria provided by our collaborative knowledge users. The criteria we
used in our protocol to begin resuscitation was a MAP <75mmHg. Once the MAP of the
animal dropped below this threshold 1ml bolus injections of the resuscitation fluid were
administered into the venous system. This process was repeated as necessary to maintain
MAP > 75mmHg. Consecutive bolus injections were often needed, however, a 5-minute
window between injections was used in order to prevent over-resuscitation due to
response from the previously injected bolus. Bolus injections were never given during the
recording of the 3-hour videos, to prevent misrepresentation in post-processed capillary
measurements.

3.3

Experimental Protocol

3.3.1 Video Recordings
After intraperitoneal injection of the FIP (baseline), the physiological status of the animal
was continuously monitored, as previously outlined. Microvascular blood flow video
sequences were taken of in-focus capillaries in 10 distinct fields of view (FOV) (one
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minute recording for each FOV). Recordings were made at baseline (after equilibration),
3 hours, and 5 hours post-injection.

3.3.2 Blood Samples
After the video sequences were recorded 250μl of heparinized arterial blood was
collected (baseline, 3, 5 hours). Once the sample was collected the blood volume was
replaced with heparinized saline. To measure systemic blood variables, an iSTAT pointof-care system was used, along with associated cartridges (CG4+: Lactate, blood gases,
CG8+: Na, K, iCa, Gluc, Hct, blood gases).

3.3.3 Capillary Analysis
Measurement of average velocity, O2 saturation, RBC supply rate, and hematocrit were
made from the analysis of the post-processed video capture sequences. All in-focus
vessels, from each field of view, at each time point, were analyzed using the same
technique. See Appendix B. The capillary bed within the muscle is inherently
heterogeneous in terms of microvascular geometry, blood flow and oxygen transport. We
attempted to obtain a representative sample by randomly selecting capillaries in 10
distinct FOV. It is expected that the impact of sepsis or resuscitation would uniformly
affect microvascular perfusion, so these data are presented as percent change from
baseline, as it is more representative of the microvascular alteration over the course of the
experiment.

3.3.4 Functional Capillary Density Measurement
Capillary densities were determined from the captured video sequences by counting the
number of capillaries that crossed three staggered overlaid test lines (200μm	
   each)	
  
perpendicular to the direction of the EDL muscle fibers	
   as	
   described	
   previously[22]..
Capillary density was counted for each field of view, at each time point, and averaged to
determine the change in capillary density over the course of the septic response.
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3.3.5 Physiological Data Analysis
The physiological data collected for the duration of the experiment was analyzed using
LabChart software. A moving average was used to analyze the collected variable signals
(MAP, CVP, CO, HR). A 300 second (5 minute) averaging window was chosen, and the
average of each interval was taken over the course of the experiment (5 hours). This was
done to eliminate major deviations within the signal in order to extract the physiological
effect of the insult alone. Stroke volume (CO x HR) and total peripheral resistance
(MAP-CVP/CO) were calculated at the culmination of the experiment. The positioning of
the cardiac output probe on the abdominal aorta is subject to variability between animals,
due to influence of the anesthetic, and the fact that the volume flow measured at this
anatomical position does not include flow to the brain, brachial arteries, kidneys liver or
the splanchnic organs. For this reason, percent change in cardiac output was used, as it is
more representative of the changes that occur over the course of the septic response. For
this reason stroke volume and total peripheral resistance are also presented as percent
change, as these calculations are reliant upon cardiac output data.

3.3.6 Statistical Analysis
The time plots of the physiological data were not analyzed statistically, and are provided
for qualitative purposes. In order to analyze the physiological data, box-and-whisker plots
were made for the 3 time point blocks (baseline, 3 hours, 5 hours) and are presented as
median and inter-quartile range (IQR). Continuous variable differences between the 4
treatment groups at the 5-hour timepoint were compared using the Kruskal-Wallis test,
followed by post-hoc analysis via Bonferri-Dunn test for multiple comparisons. The
capillary data are presented as mean ± standard error of the mean (SEM). These data
were analyzed by one-way analysis of variance (ANOVA) with post-hoc Bonferri-Dunn
test for multiple comparisons. A p-value of 0.05 was considered significant. For
simplicity, significance is presented for the 5-hour time point only.
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Figure 3-1 Timeline of study for animal model. Blue arrows indicate the timing of video
captures, as well as timing of blood collection. Red asterisk indicates administration of
FIP, and BL indicates the timing of baseline measurement collection. The animal is
minimally resuscitated with an infusion of saline (0.9%, 0.5 ml/hr), until MAP drops
below the 75mmHg threshold, at which point, bolus injection of the resuscitation fluid
are implemented to maintain this parameter. MAP, HR, CVP, and CO are measured for
the entire observation period.

3.4

Results

The global variables (Table 3-1) were not significant; however the FIP and FIP+Saline
groups levels are indicative of hyperlactatemia The FIP+Saline and FIP+Albumin groups
had lower hematocrit, and lower PaO2..
Although this is a preliminary study (n=3 per group) the administration of the different
fluids caused differences in terms of macrovascular and microvascular response. Figure
3-2 shows the average physiological parameters for each group over the entire course of
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the experiment. Individual animals in all FIP groups dropped below the MAP threshold at
some point during the experiment. There was a significant difference in MAP (Fig. 3-3A)
at 5 hours for the FIP and FIP+saline groups compared to sham-operated control. All of
the septic animals had decreased MAP compared to baseline. For CVP, FIP+Albumin
group was significantly decreased (Fig. 3-3B) as compared to the sham-operated animal at
5 hours. The FIP animal had significantly decreased heart rate from baseline (Fig. 3-3C),
and as compared to 5-hour sham animals. Both FIP and FIP+Saline groups had
significantly decreased cardiac output (Fig. 3-3D) compared to baseline. The FIP and
FIP+Saline groups had significantly increased TPR (Fig. 3-3E) compared to both the 5hour sham, and 5-hour baseline measurements, while the FIP+Albumin group had
significant decreased TPR compared to baseline. Lastly, the FIP and FIP+Saline groups
had significantly decreased stroke volume (Fig. 3-3F) compared to baseline, and the FIP
group also was significantly decreased compared to the 5-hour sham. None of the data for
the raw microvascular data was significant.
The only data that was significant for the normalized microvascular analysis was a
significant decrease in stroke volume for the FIP+Saline group compared to baseline
(Fig. 3-5D). Qualitatively, for the velocity (Fig. 3-5A), oxygen saturation (Fig. 3-5B) and
stroke volume (Fig. 4D) the FIP and FIP+Saline groups follow a similar trend, declining
in a linear fashion throughout the course of the experiment. The FIP+Albumin group
followed a similar trend in these measurements from baseline to 3 hours; however, in all
3 measurements, the trend reversed and increased from 3 hours to 5 hours. In terms of
hematocrit (Fig. 3-5C) the FIP and FIP+Albumin groups increased from baseline, whereas
the FIP+Saline group decreased from baseline. Similarly, there was no significant change
in the functional capillary density data.
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Sham	
  

FIP	
  

FIP	
  +	
  Saline	
  

FIP	
  +	
  Albumin	
  

n	
  

2	
  

2	
  

2	
  

2	
  

Weight	
  (g)	
  

172.5	
  

200	
  

174	
  

175	
  

pH	
  

7.482	
  

7.347	
  

7.333	
  

7.314	
  

PaO2	
  (kPa)	
  

121	
  

106	
  

87	
  

73	
  

PaCO2	
  (kPa)	
  

33.6	
  

40.6	
  

27.6	
  

45	
  

Glucose	
  (mmol/L)	
  

7.5	
  

4.25	
  

4.8	
  

5.2	
  

Lactate	
  (mmol/L)	
  

0.783	
  

2.165	
  

2.775	
  

0.8	
  

Hemoglobin	
  (g/dl)	
  

127.5	
  

159.5	
  

88	
  

116	
  

Hematocrit(%)	
  

0.375	
  

0.47	
  

0.26	
  

0.34	
  

N/A	
  

N/A	
  

5.5	
  

3	
  

Additional	
  Fluid	
  for	
  
Resuscitation	
  (ml)	
  

Table 3-1 Arterial blood measurements (via iSTAT) for Sham, FIP, FIP+Saline and
FIP+Albumin groups. Data shown are averages of 2 animals in each group, 5 hours after
septic insult. Average fluid required to achieve physiological target are also shown where
appropriate.
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Figure 3-2 Physiological parameters of sham-operated, septic (FIP), septic (FIP-Saline
resuscitated), septic (FIP-Albumin resuscitated) rats (n=3). (A) Mean arterial pressure,
(B) Central Venous Pressure, (C) Heart Rate, (D) Cardiac Output, (E) Total Peripheral
Resistance (F) Stroke Volume. The mean arterial pressure graph has a superimposed line
(75mmHg) illustrating our hemodynamic optimization target.
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Figure 3-3 Physiological parameters of sham-operated, septic (FIP), septic (FIP-Saline
resuscitated), septic (FIP-Albumin resuscitated) rats (n=3). (A) Mean arterial pressure,
(B) Central Venous Pressure, (C) Heart Rate, (D) Cardiac Output, (E) Total Peripheral
Resistance (F) Stroke Volume are displayed for each time point (baseline, 3 hours, 5
hours) as median (IQR). *Difference at 5 hours between septic animals and sham (P
<0.05). #Difference within group between 5 hour and baseline measurement (P<0.05).
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Figure 3-4 Microvascular parameters of sham-operated, septic (FIP), septic (FIP-Saline
resuscitated), septic (FIP-Albumin resuscitated) rats (n=3). (A) Velocity (B) Oxygen
Saturation (C) Hematocrit and (D) Supply Rate are displayed for each timepoint as mean
and individual animal values.
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Figure 3-5 Microvascular parameters (normalized to baseline) of sham-operated, septic
(FIP), septic (FIP-Saline resuscitated), septic (FIP-Albumin resuscitated) rats (n=3). (A)
Velocity (B) Oxygen Saturation (C) Hematocrit and (D) Supply Rate are displayed for
each timepoint as mean and individual animal values. #Difference within group between
5 hour and baseline measurement (P<0.05).
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Figure 3-6 Functional capillary density measurements of sham-operated, septic (FIP),
septic (FIP-Saline resuscitated), septic (FIP-Albumin resuscitated) rats (n=3). (A)
baseline (B) 3 hour and (C) 5 hour functional capillary densities are shown. Capillaries in
each field of view are categorized as continuous, intermittent, or stopped depending on
degree of RBC transit. Data are presented as mean ± SEM .
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3.5

Discussion

The debate as to which fluid is best used for the resuscitation of septic patients to achieve
macrovascular optimization has not been resolved[6, 8, 14]. It is well known that early
fluid resuscitation of septic patients improves survivability; however the effect of
administered fluid on the microvascular environment is rarely considered[2]. It has been
shown that microcirculatory dysfunction is a major contributor to global tissue hypoxia,
which eventually leads to multiple organ failure[1]. Thus, the ability to test common
clinical therapies aimed at optimizing macrovascular hemodynamic targets, and elucidate
the associated effect on the microcirculation could provide valuable information with
important clinical implications. In this preliminary study, we demonstrated the unique
ability to test the effect of fluid resuscitation on the microvascular environment in a
translational animal model of sepsis.
While the data presented are preliminary, the trends in the macro- and the
microcirculatory environments are encouraging. With our developed translational animal
model, we are able to consistently replicate the transition from pre-sepsis to sepsis. See
Appendix C. The FIP animals all exhibited the systemic changes commonly associated
with an early septic response (drop in cardiac output, increased total peripheral
resistance) (Figs. 3-2, 3-3). Interestingly, the administration of bolus albumin was able to
decrease these trends and had an increased cardiac output, and decreased total peripheral
resistance compared to the 3-hour time point. Albumin resuscitation was also better able
to maintain blood pressure about 75mmHg, evidenced by the amount of bolus injections
administered, compared to saline. This makes sense given the properties of albumin, and
the ability to maintain colloid osmotic pressure. In terms of stroke volume, the FIP, and
FIP+Saline groups decreased from the onset of sepsis, while the FIP+Albumin group
followed a similar trend at the 3-hour time point; however, much like cardiac output and
total peripheral resistance, the trend reversed at the 5-hour time point, leading to an
increased stroke volume. Taken together, it appears that at the macrovascular level,
albumin is able to better restore hemodynamic parameters.
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The trends at the microcirculatory level are similar (Figs. 3-5). In terms of velocity,
oxygen saturation, and supply rate in the capillaries, both the FIP and FIP+Saline groups
decline in a linear fashion after initiation of the sepsis. The albumin-resuscitated group
similarly declined from baseline; however after the 3-hour time point, and the associated
administration of bolus albumin injections, the trend reversed, and all three parameters
increased. The hematocrit increased in the FIP and albumin groups, and decreased in the
saline group. For the FIP group this could be due to vascular leak, which decreases the
plasma volume. For the FIP+Albumin group, the increase in hematocrit could be
attributed to the increased velocity and supply rate.
The trends in functional capillary density (Fig. 3-6) were that in the FIP and FIP+Saline
groups, there was an increase in intermittent flow capillaries over the course of the
experiment and a related decrease in continuous flow capillaries. The FIP+Albumin
group had an increase in intermittent flow capillaries, but reversed this trend at the 5-hour
time point. These trends are indicative of capillary functionality, as an increase in stopped
flow capillaries has previously been shown to increase in sepsis[22]. While there was not
an increase in the amount of stopped flow capillaries for the septic animals, the increase
in intermittent flow is potentially an early indicator of microvascular dysfunction. In
order to be able to analyze capillaries quantitatively, there needs to be RBC transit. While
an increase in the amount of intraperitoneal FIP administered would cause a more severe
septic response, which would promote an increase in stopped flow capillaries, we would
have to lose vessels for our hemodynamic and O2 measurements, which are a pivotal
advantage of our animal model.
In terms of clinical inclusion criteria, we used a mean arterial pressure of 75mmHg as our
resuscitation target, which is only one part of sepsis inclusion criteria. Besides mean
arterial pressure, temperature >38oC or <36oC, respiratory rate >20 breaths/minute or
PaCO2 <32 mmHg, heart rate>90 beats/min, and WBC count >12,000 cells/mm3 or
<4,000 cells/mm3 are also considered indicators of sepsis. Due to the use of pentobarbital
anesthetic we are unable to use time until respirator requirement as a metric of sepsis
onset, and the respiratory rate is controlled throughout the experiment. We are able to
take blood samples to measure PaCO2; however, the sample requires 250µl blood draws,
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making regular sampling over the course of the experiment subject to hemodilution. This
is the same issue with measuring WBC count regularly. We also maintain internal
temperature of 37oC over the course of the experiment. In addition, it is clinically
common to measure mixed venous oxygen saturation, which is difficult in our model due
to the positioning of the jugular vein catheter. Unlike the carotid artery, blood does not
passively flow out of the jugular catheter, thus measurement requires drawing the blood
with a syringe. The clotting nature of blood requires this process to be done very quickly,
and if the blood is not totally flushed from the line, will risk forfeiting CVP monitoring
for the rest of the experiment. For these reasons our use of MBP < 75mmHg made the
most sense given our instrumentation, and the physiological similarity in values as
compared to a human (Appendix C).
Although more experimentation with these fluids needs to be done in order to truly show
fluid resuscitation efficacy, it appears that albumin is a more effective fluid at restoring
both microvascular and macrovascular targets. Interestingly, although saline was able to
restore the blood pressure values, cardiac output, and microvascular parameters continued
to decline, which supports the notion that hemodynamic optimization is not reflective of
the microvascular environment surrounding in vital organs. Furthermore, the successful
application of this model and the promising ability of deducing mechanistic effects of
fluid resuscitation, demonstrate the fidelity of our animal model, and encourages the use
of this model for future sepsis research applications. Subsequent experiments, and
additional instrumentation will only further improve upon our animal model, and will
continually improve translational research and education.

3.6

Conclusion

We demonstrated the unique ability to monitor systemic physiological parameters over
the course of a septic insult, and couple these data to microvascular data in the hindlimb
muscle. Coupling these measurements we tested clinical fluid resuscitation protocols
using both saline and 5% human albumin, two of the most commonly used, and
commonly debated fluids. Our preliminary findings indicate that albumin is better at
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restoring macrovascular homeostasis, as well as restoring microvascular perfusion and
oxygenation in sepsis.
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Chapter 4
Contributions, Limitations and Future Directions
4.1

Contributions

Recently, there has been a call for animal models of sepsis that are more representative of
the clinical scenario. There is a noticeable disconnect between preclinical experimental
findings, and successful translation to the clinical environment, which is illustrated in the
failure of many multi-center clinical trials. While success in human patient cohorts is
important, animal models remain as essential tools in developing new therapies and
determining the mechanism of clinical interventions.
While many models of sepsis are currently in use, each with distinct advantages, there is
still a need for high-fidelity animal models that can be adapted depending on the needs of
critical care[5].
In addition, the ability to provide macrovascular and microvascular data, in conjunction
with a controlled septic insult, is of utmost importance, especially considering that the
microcirculation is being recognized as an important target for early goal-resuscitation
therapies[15, 33].
The goal of this thesis was to develop an animal model of sepsis, building on the
recommendations of ICU physicians, that is more relevant to the clinical septic response.
We have demonstrated a dual-sided approach that provides concurrent macrovascular and
microvascular data, over the entire course of a FIP-induced sepsis insult. Our use of FIP
to induce sepsis allows for a greater degree of control than other more variable models
such as CLP, which is still considered the gold standard. The commonality of the CLP
lies in the ability to replicate the events associated with the early phase of a septic
response (low CO, high TPR), which our FIP insult is also able to reproduce. The unique
ability of our model lies in our high-level instrumentation, which provides physiological
data similar to what would be available for a patient in the ICU. Our use of a dualwavelength camera allowed us to extract valuable quantitative microvascular data, which
provides insight into the environment that may be surrounding the vital organs. As
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current clinical microvascular data uses the sublingual microcirculation to assess degree
of dysfunction, we are able to apply the same principles in an organ remote to the site of
initial infection. A further advantage of our model lies in the ability to extract oxygen
saturations for individual capillaries, effectively removing reliance on purely qualitativebased assessment of microvascular perfusion. This aspect of our model has many
implications in terms of future applications of the model aimed at determining the
mechanistic effect of therapeutics. Applying our model in this manner was the secondary
goal of this thesis.
The secondary aim of this thesis was to apply our developed model in an attempt to
address the efficacy of saline and albumin as resuscitation fluids. Guided by our research
colleagues (Dr. Michael Sharpe, University Hospital, London, ON – Critical Care and
Anesthesia, and Dr. Alison Fox-Robichaud, McMaster Hospital, Hamilton, ON – Internal
Medicine, Critical Care) and the Canadian Critical Care Translational Research Group,
we decided that the first application of our model would test the efficacy of fluid types
using current clinical diagnostic criteria. In our preliminary study we administered either
saline or albumin in order to maintain systemic blood pressure of 75mmHg or greater.
We demonstrated our ability to illustrate the mechanistic effect of fluid type on
macrovascular and microvascular environment in sepsis. While saline and albumin were
both able to restore blood pressure, the trends at the 5-hour timepoint for other systemic
parameters were different. Saline was unable to improve cardiac output, stroke volume,
and maintained increased TPR, while albumin had the opposite effect, increasing cardiac
output, and stroke volume, and decreasing TPR. The situation at the microvascular level
was similar. In terms of oxygen saturation, velocity, and supply rate, saline animals
declined over the course of the response, while the animals in the saline group increased
after administration of an albumin bolus. These results suggest that albumin may provide
a therapeutic benefit beyond hemodynamic optimization, and is more effectively at
restoring systemic homeostasis than saline.
In addition to providing evidence for the use of albumin in fluid resuscitation, we
developed a fluid resuscitation model of sepsis that can be tested in conjunction with
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other therapies, co-morbidities, and disease severities to further increase the translational
ability of our model.
This translational tool has several potential applications, and addressed many of the
drawbacks of previous models that have been recently examined[1]. This model has
several potential additions that will strengthen its integrity, and it is well set-up for
modifications, as needed, to meet the demands of critical care research.

4.2

Limitations/Additions

The limitations of these studies are mainly technical, and involve the instrumentation of
the rat in our protocol. Some of these were alluded to in the discussion of the previous
chapters.
Since we are mechanically ventilating the rat with a preset ventilation rate (generally 7376 breaths/min), applying a positive end expiratory pressure (PEEP) would be a valuable
addition to our model. Currently we relied on the PaO2 and PaCO2 values measured via the
iSTAT cartridges and arterial blood samples to determine the ventilation rate, but these
measurements provide little indication about respiratory distress. By changing the
ventilator that we use we would be able to apply a PEEP within our animals. The
application of PEEP would be valuable to ensure airways stay open, which would offset
acute respiratory distress syndrome (ARDS), and respiratory failure due to edema
formation.
Second, catheterization of the bladder to monitor urine output is another potential
addition to our model, which would provide another measurement common in clinical
practice. While we did not include this procedure in our current protocol, the technique
to catheterize the bladder of a male within the peritoneal cavity has recently been
developed[4]. Due to our use of pentobarbital anesthetic this catheterization technique is
necessary, as urine does not passively flow, as the central nervous system is depressed.
This technique would be a valuable addition to the model, and would provide insight into
the degree of kidney dysfunction in the rat, adding another aspect of clinical inclusion
criteria. We make a midline incision for the implantation of the cardiac output flow
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probe, which makes the bladder catheterization accessible. The reason that we did not
include this in the original model is due to the difficulty of surgery, and the fact that the
suggestion of this technique came after several animal experiments were completed. Due
to the increased inflammation that would occur due to the extra surgery, we did not want
to introduce unnecessary variability into our experiment.
Next, measurement of mixed venous saturation would improve upon the clinical
relevancy of our model. Mixed venous oxygen saturation is another target common to
early-goal directed therapies, and is often used as a metric of imbalance between oxygen
delivery and systemic oxygen consumption[3]. Although we rely on MAP to guide our
resuscitation protocols, it would be worthwhile to monitor consistent changes in mixed
venous oxygen saturation to get a sense of how accurate reliable it is as a tissue perfusion
surrogate. Continuous measurement of venous oxygen saturation is possible using an
implanted fiber-optic catheter, and has been demonstrated in newborn infants[5]. Barring
the lack of instrumentation in our lab, we could adapt this technique for use in our model,
as we already catheterize the jugular vein, thus extra surgery would not be required.
Measurement of white blood cell count during the experiment would be another valuable
addition to our model in terms of clinical indications of sepsis (WBC ct. >12 or <4).
Performing a complete blood count at each timepoint could provide information about
platelets as well, which is another measurement common to the bedside. Currently this
test is not performed due to time constraints in the experimental protocol, however could
be added with the help of additional personnel.
Another addition that could be useful in terms of our model would be if we had the
ability to monitor the amount of applied heat required to maintain core body temperature
of 37OC. In the clinical setting patients becoming either hypothermic (temp <36OC) or
hypothermic (temp > 38OC) is an indicator of systemic inflammation. Monitoring the
amount of applied heat would provide insight into the temperature control abilities of
septic animals.
In addition, given that we continuously monitor systemic parameters over the course of
the septic insult, it would be interesting to look at heart-rate variability. Heart-rate
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variability analysis can provide insight into myocardial distress, which could provide
insight into the cardiac output trends that are seen in the septic animals. This data has
already been acquired, and thus analysis of the data is possible to determine the effect of
sepsis on heart rate variability in our model. This also has clinical implications as heartrate variability can easily be measured in human patients, and may have predictive
effects.
Lastly, at the end of the experiment, the vital organs were harvested (kidney, spleen,
liver, skeletal muscle, diaphragm, lung, heart, and brain) and stored for future use. These
tissues could be used for genomic analysis in order to measure gene expression in sepsis.
Our institution has the infrastructure to analyze the entire genome of the rat (London
Regional Genomics Centre, Robarts Research Institute, London, ON). This analysis could
provide valuable information about which genes are upregulated in sepsis, and how the
administration of fluids or therapeutics affects this regulation. This also has clinical
implications as patient blood samples are often taken in an attempt to detect early
markers of sepsis (e.g. IL-6, TNF-α), which can be used to aid in therapeutic
decisions[6].

4.3

Future Work

In terms of future work, there are several potential experiments that involve applications
of our model.
As was previously alluded to in the introduction of this thesis, the developed central
model permits adaptability and introduction of co-morbidities is a logical next step
application. Since septic patients commonly have co-morbidities, the ability to test the
septic response in a variety of cases would provide valuable insight in terms of patient
screening, and illustrate if specific cohorts of patients are better suited to specific
therapies. For instance, using a diabetic animal, or an animal with cardiovascular disease,
would provide valuable information about a common clinical comorbidity present in
septic patients.
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It also follows, since the preliminary application of our model was to test albumin and
saline, that we could also test other fluids, or administer blood transfusions. In this way
we would be able to deduce which fluid best achieves clinical targets, as well as restoring
microvascular perfusion. Along the same lines, testing concomitant therapies would be
another useful application of this model and would improve clinical adaptability, as
patients commonly receive more than just fluids for treatment (e.g. vasopressors,
inotropic agents, antibiotics)[7].
It would also be valuable to demonstrate the validity of our use of the EDL as
representative vasculature in the vital organs. It would be valuable to use near infrared
spectroscopy (NIR) in easily accessible vital organs (kidney, brain) in order to assess
changes in oxygen saturation over the course of the septic response.
Since platelet aggregation is associated with the inflammatory response, the ability to
visualize platelets in conjunction with our dual-wavelength technique for capillary
oxygen saturation measurements would provide valuable information. This would be
especially useful for fluid resuscitation, as albumin is believed to have anti-inflammatory
properties, which this technique would be able to visualize. This could be accomplished
through the use of spinning disc confocal microscopy, and fluorescent labeling of
platelets. After the dual-wavelength videos were captured, the cameras could be switched
to the fluorescent channel, and the platelets in the same channel could be visualized.
Furthermore, as sepsis is associated with endothelial dysfunction, which causes fluid to
leak out of the vasculature, it would be interesting to be able to monitor the degree of leak
in sepsis, and compare the effect that fluid resuscitation has on edema formation. Using a
dye such as Evans blue would permit this measurements, as it can be injected into the
animal ~2 hours before sacrifice (which corresponds to onset of sepsis in our model and
after the animal is sacrificed, the tissues could be homogenized, and the dye
concentration determined using a spectrometer. This experiment would provide insight
into the areas of the animal that are most susceptible to vascular leak, and allow us to see
where resuscitation fluid was collecting. This experiments would further our comparison
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between resuscitation fluids, as the interaction of specific fluids and the edematous tissue
could be considered.
Lastly, this model could serve as a valuable education tool, as we were able to effectively
create a miniature ICU. Clinicians or residents hoping to gain experience in treating a
septic patient would be able to obtain real-time training, and would be able to intervene,
as they deem necessary, based on the same parameters that are available at the bedside.
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Appendix B: Camera Set-Up, Flow-Probe Measurement
Dual-wavelength intra-vital video microscopy
In our experiment we use dual wavelength microscopy to take advantage of the
differences in absorption spectra of oxy- and deoxyhemoglobin at specified wavelengths
(Fig. 4-1). The extraction of capillary SO2 from the dual-wavelength capture is based on
the equation for the optical density of whole blood at a particular wavelength given by:

𝑂𝐷! = 𝜖!! 𝐻𝑏𝑂! 𝑑 + 𝜖!! 𝐻𝑏 𝑑

(1)

Where 𝜖!! is the extinction coefficient of oxyhemoglobin at the selected wavelength, 𝜖!! is
the extinction coefficient of deoxyhemoglobin at the same wavelength, 𝐻𝑏𝑂! is the
concentration of oxyhemoglobin,   𝐻𝑏 is the concentration of deoxyhemoglobin, and d is
the path length of light.
By measuring the optical density in our video captures images at two wavelengths (442nm –large absorption difference, 454-nm – no absorption difference) we can calculate the
ratio of the optical densities, and hence the oxygen saturation via the equation:
𝑆𝑂! = 𝑚  

𝑂𝐷!
+   𝑏
𝑂𝐷!

(2)

where 𝑂𝐷! is the optical density from (1) where there is a large difference in absorption
(442-nm) , 𝑂𝐷! is the optical density from (1) where there is no difference in absorption
(454-nm), and the slope, m, and intercept, b, can be calculated by substituting the 𝑂𝐷!
and 𝑂𝐷! in the form of (1) and the fact that 𝑆𝑂! =

[!"#! ]
[!! ]

that is, the concentration of

oxyhemoglobin divided by the total concentration of hemoglobin[1].
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White light from a xenon light source transilluminates the capillary network, and the
image is duplicated using a beam splitter, with band-pass interference filters for the
selected wavelength (Fig.4-1), and subsequently captured with two separate digital
cameras. The images are then post-processed to generate functional images by methods
developed by Japee et. al. [2].
The functional images are used by proprietary software developed in our laboratory to
trace the in-focus capillary and create space-time images (S/T images). These images are
created based on the location of the capillary wall, and the location of the RBCs within
the capillary column. The space-time image is a time series plot of the movement of
RBCs through the capillary over the course of the video capture. The created plots
illustrate the change in location of RBCs in the capillary with respect to time, and can be
used to measure RBC velocity (µm/s) in capillaries based on the frame-by-frame
displacement of RBCs and plasma gaps over the course of the video capture. Supply rate
(# of cells/s) can also be deduced based on the velocity of the RBCs in the column and
the lineal density (RMCs/mm), which is based on spatial average of optical density over
the capillary length. The calculations are carried out using proprietary analysis software
developed in our laboratory that utilizes previously developed techniques to extract
capillary data for analysis of the microvascular environment [3]. The measurements that
we consider include: velocity, oxygen saturation, supply rate, and capillary diameter. A
pictorial representation of capillary data extraction is provided (Fig. 4-2).
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Figure 4-1 Absorption spectra of human hemoglobin. The superimposed lines indicate
the wavelengths that our camera capture system utilizes. The 454-nm wavelength is
isosbestic, and the 442-nm wavelength is differentially absorbed by oxyhemoglobin
(HbO2) and deoxyhemoglobin (Hb).
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Figure 4-2 Experimental camera capture, and analysis set-up. During the experiment,
dual-wavelength intra vital video microscopy is used to monitor capillary blood flow in
the hindlimb muscle of the rat. The dual wavelength capture (20X) is then post-processed
to create SAD images, which are used by the vessel selection GUI to trace the in-focus
capillaries, and create space-time (S/T) images. The S/T images are then used by the
vessel analysis GUI to calculate changes in velocity, hematocrit, supply rate, and oxygen
saturation over time, using the data contained in the S/T image. This process is repeated
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for the in-focus capillaries in 10 fields of view to assess the global tissue microcirculatory
environment.

Transonic Flow Probe Cardiac Output Monitor
The flow probe that was used to monitor cardiac output was a Transonic 2PSB (2mm)
probe. The probe head consists of two ultrasonic transducers attached on a cuff that are
positioned on one side of the vessel being monitored. The cuff on the probe head is
associated with a metal reflector that is fixed in place on the side of the vessel opposite
the transducers. The reflector acts to redirects the ultrasound signal emitted from one of
the upstream transducers, through the vessel to the upstream transducer. The time it takes
the signal to traverse this path is associated with the flow of the vessel within the cuff
(Fig. 4-3)
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Figure 4-3 Schematic representation of transonic flow probe used to monitor cardiac
output. The transducer heads emit a wide ultrasound beam, passing signals back and forth
to monitor the transit time in the upstream and downstream directions. The difference in
these measurements reflects the volume flow of the vessel.
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Both upstream, and downstream transit time measurements are made, which is carried out
by reversing the transmit-receive sequence between the transducer heads. The output
cardiac output signal is the difference of the upstream and downstream transit time, as the
upstream signal is going against the “current”, while the downstream signal is going with
the “current” thus each metric is needed for signal accuracy. Each transducer emits a
wide-beam signal, which ensures that the volume flow calculation is accurate. The fact
that the beam intersects the vessel twice (once on transmission, and once on receiving
end) decreases the effect of diameter differences and vessel alignment issues, thus
allowing for reliable implantation and measurements.
There are a few limitations to the use of the cardiac output probe. These include the
placement of the probe anatomically, and the use of anesthetic. Since cardiac output is a
measure of the total volume of blood pumped from the heart per minute, the further away
from the aorta the greater the misrepresentation of the measurement. Thus our use of
measurement on the abdominal aorta does not include flow to the brain, or flow in the
brachial arteries and forelimbs. Next, it has been shown that pentobarbital anesthetic
depresses cardiac output in rats, and thus it will cause cardiac output to be lower than
expected. For these reasons it makes sense to measure relative change in cardiac output
from baseline, rather than attempting to compare cardiac outputs across groups due to the
high potential for confounding variables.
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Appendix C: Protocol Modifications
The first chapter describing the development of the animal model underwent several
protocol modifications. This appendix will describe these modifications, the associated
problems with each objective, and the most effective resolutions. This appendix aims to
mitigate these obstacles for trainees hoping to utilize this animal model in the future.

Modification 1 – Non Fluid-Resuscitated CLP
The first objective in the development of this model was to fully instrument the animal in
order to consistently obtain macrovascular measurements (MAP, HR, CO, CVP, Urine
Output). Next, we initiated sepsis using the CLP method. The EDL was then bluntdissected as described in Chapter 2, and the animal was transferred to the microscope
stage. The total number of rats used in the development of this preliminary model was
eighteen (n=18). The number of animals attributed exclusively to each challenge is
indicated.
Challenges
Probe (nprobe = 6): The placement of the flowprobe was the source of several issues as
manipulation of the inferior vena cava is a fragile process. The process of separating the
connective tissue that attaches the abdominal aorta and the inferior vena cava is difficult
and requires careful surgery. Furthermore, upon separation of the membrane the direction
that the flowprobe cuff encircles the abdominal aorta is important. Both of these issues
were considerable sources of difficulty in the preliminary stages of this model and were
addressed as follows:
1) To separate the membrane between the inferior vena cava and the abdominal
aorta, the first step is to use cotton swabs to separate the superficial membranous
tissue. Once this is complete, blunt, curved forceps must be used to slightly pick
up the abdominal aorta, from the right (anatomical left) side. The forceps tips
should be seen through the connective tissue (between the vena cava and
abdominal aorta), when viewed through a surgical microscope. Continuing to use
the surgical microscope, a pair of serrated straight forceps must be used from the
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left (anatomical right) side to tease away the connective tissue, in between the
vena cava and abdominal aorta, with the majority of the force applied to the tips
of the blunt curved forceps lying underneath. The force must be applied to the tips
of the forceps favoring the left side, towards the vena cava, as force in the
opposite direction (towards the abdominal aorta) will cause the vena cava to tear,
effectively ending the experiment.
2) Once a hole is made in the membrane, the process should be continued vertically
until the hole is big enough to fit the flowprobe cuff. After the hole is made, the
flowprobe cuff must encompass the abdominal aorta by first being inserted
through the hole, underneath the aorta, and exiting out the right (anatomical left)
side. This specific direction is needed such that when the animal is rotated on the
stage the aorta will fall into the probe head, and will not slip out when the animal
is transferred to the stage.
CLP (nCLP= 4): The CLP surgery was the source of problems, as the procedure requires
manipulation of the cecum, tying off of the supplying blood vessels, perforation of the
membrane, and palpation of the cecum to release fecal contents. Besides the surgical
challenge, it is difficult to exactly replicate the amount of feces that is extruded.
Furthermore, the surgery is not possible to perform on the microscope stage, and thus the
time between initiation of insult, and transfer to the stage is sufficient such that true
baseline measurements cannot be obtained. Due to this transfer time, the initial
measurements were made at least one hour after the initial insult, and thus do not
represent a true baseline. This issue was addressed via the use of FIP instead of CLP to
induce sepsis. Using a FIP model allowed us to transfer the animal to the stage, and then
administer the initial insult, significantly reducing the time between insult and baseline.
Adapting the insult in this way provided us with baseline measurements that were as
close as possible to a baseline.
Urine Output (nUrine=4): As urine output is used clinically as an indicator of renal
failure, we attempted to catheterize the bladder of the rat in order to add this
measurement to our model. This surgery is invasive and it was difficult to find a detailed
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protocol describing this method. Due to several failed surgical attempts, and the
associated termination of data acquisition, the catheterization of the bladder was
abandoned as an addition to the model. Further training may be required in order to add
this measurement to the model.
Video Recordings (nVideo=18*): The video recordings are an integral part of our model
because they allow us to monitor changes in the microcirculatory environment in the
EDL over the entire course of the septic insult. While the protocol modifications
eventually led to baseline video captures immediately following septic insult, we
eventually realized that we needed to add a middle timepoint in order more effectively
track the progression of sepsis at the microcirculatory level. *Note: due to the fact that
the video capture protocol does not affect animal survivability, this n-value indicates the
number of animal experiments that were carried out without a middle (3-hour) timepoint.
Conclusion
In developing this preliminary model we realized the importance of a true baseline when
considering the septic response. We also realized the importance of consistent placement
of the abdominal flowprobe to prevent premature termination of the experiment due to
the surgical procedure. We also realized the difficulty required to obtain urine output
measurements, and thus sacrificed this addition to the model. Lastly, we realized the
importance of the 3-hour timepoint in order to better track the microcirculatory response
to the septic insult.

Modification 2 – Resuscitated FIP Model
The second objective after the initial development of the model was to begin
implementing clinically relevant resuscitation strategies upon diagnosis of sepsis. This
secondary protocol underwent several modifications regarding the severity of the initial
insult (FIP), the criteria for diagnosing our animal as septic, and the procedure for
providing fluids to the animal. The total number of rats used in the development of this
model was eighteen (n=18). The number of animals attributed exclusively to each
challenge is indicated.
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Challenges
Sepsis diagnosis (nDiagnosis=4): The diagnosis of our animals as septic was an important
addition to this model, and was based on input from ICU physicians. In the first stages of
this model, the animal was considered septic at the 3-hour timepoint (not based on
systemic parameters). This protocol was adapted such that sepsis diagnosis was based on
mean arterial pressure dropping below 75mmHg consistently for 5 minutes. This
adaptation was very important to increase clinical relevance, as we introduced sepsis
diagnosis based on common clinical inclusion criteria. The clinical inclusion criteria is
MAP < 65 mmHg. The reason for the increase used in our model is explained in the next
section regarding the severity of the FIP insult. Briefly, animals in the untreated FIP
group would not survive to the 5-hour timepoint if the insult was severe enough to drop
blood pressure below 65 mmHg around the 3-hour timepoint of the experiment. This
adaptation was also very important in terms of guiding our fluid-resuscitation strategy.
We would begin administering fluids to animals in the treatment groups upon diagnosis
of sepsis, and would continue to provide fluids until the animal’s blood pressure could be
maintained (MAP> 75 mmHg).
Severity of FIP (nSeverity=10): The severity of the initial insult had to undergo continual
modification as the FIP animals had to become septic, and also survive until the 5-hour
timepoint. This process was especially difficult in the non-resuscitated FIP group, as the
untreated animals would rarely survive until 5 hours if sepsis was diagnosed around the
3-hour timepoint. This step in the protocol involved several modifications to the volume
of the FIP insult; too little insult would result in a non-septic animal, whereas too large of
an insult would cause the premature termination of the experiment. Eventually an
effective dose for the sake of our experimental protocol was realized, which is presented
in Chapter 2.
Gradual vs. Bolus Fluid-Resuscitation (nGradual=4): For the animals in the resuscitation
group, we initially began resuscitation via a gradual infusion of fluid, rather than a bolus
injection. Upon discussion with our collaborators (ICU physicians) we decided that bolus
injections were more clinically relevant. Thus the final modification to the protocol was
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to resuscitate the animals to achieve the clinical target (MAP > 75 mmHg) using
successive 1 ml bolus injections as needed.
Conclusion
In the development of this secondary model we realized the importance of diagnosing
sepsis based on clinical criteria. We also determined that MAP < 75 mmHg was effective
to use as our sepsis inclusion criteria. This method also helped to ensure that our fluidresuscitation strategy was based on a physiological parameter, and the animals were
treated consistently between groups. These modifications also led to the most effective
FIP insult volume such that the animals became septic during the experiment, but the
untreated animals could survive until the 5-hour timepoint. Lastly, the final modification
enhanced the clinical similarity of our resuscitation protocol, and we determined that
bolus injections should be used to fluid resuscitate.

Final Model – Translational FIP Model of Sepsis
Once all of the obstacles mentioned above were overcome, we decided our protocol was
clinically relevant and began applying our model to test the efficacy of fluid type on the
macrovascular and microvascular environment in a rat FIP model of sepsis. The number
of animals included in the final model was twelve (n=12) and are presented in this thesis.
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